Annotation Detail for EGFR
Basic Information Top
| Gene Symbol: | EGFR ( ERBB,ERBB1,HER1,PIG61,mENA ) |
|---|---|
| Gene Full Name: | epidermal growth factor receptor |
| Band: | 7p11.2 |
| Quick Links | Entrez ID:1956; OMIM: 131550; Uniprot ID:EGFR_HUMAN; ENSEMBL ID: ENSG00000146648; HGNC ID: 3236 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa05160 | Hepatitis C |
| hsa04912 | GnRH signaling pathway |
| hsa04012 | ErbB signaling pathway |
| hsa04010 | MAPK signaling pathway |
| hsa04020 | Calcium signaling pathway |
| hsa04144 | Endocytosis |
| hsa04320 | Dorso-ventral axis formation |
| hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
| hsa04540 | Gap junction |
| hsa05219 | Bladder cancer |
| hsa04520 | Adherens junction |
| hsa05223 | Non-small cell lung cancer |
| hsa04810 | Regulation of actin cytoskeleton |
| hsa05218 | Melanoma |
| hsa05212 | Pancreatic cancer |
| hsa05213 | Endometrial cancer |
| hsa05214 | Glioma |
| hsa05215 | Prostate cancer |
| hsa04510 | Focal adhesion |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Axon guidance | |
| Signaling by EGFR |
| Pathway ID | Pathway Name |
|---|---|
| 200033 | Signaling events mediated by PTP1B |
| 200136 | ErbB receptor signaling network |
| 200155 | Stabilization and expansion of the E-cadherin adherens junction |
| 200146 | Internalization of ErbB1 |
| 200125 | E-cadherin signaling in keratinocytes |
| 200085 | EGF receptor (ErbB1) signaling pathway |
| 200069 | Thromboxane A2 receptor signaling |
| 200060 | Arf6 signaling events |
| 200065 | Signaling events mediated by TCPTP |
| 200095 | EGFR-dependent Endothelin signaling events |
| 200170 | Syndecan-3-mediated signaling events |
| 200072 | Regulation of Telomerase |
| 200162 | a6b1 and a6b4 Integrin signaling |
| 200011 | LPA receptor mediated events |
| 200113 | ErbB1 downstream signaling |
| 200101 | Direct p53 effectors |
| Pathway ID | Pathway Name |
|---|---|
| P00018 | EGF receptor signaling pathway |
| P00012 | Cadherin signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500510 | Signaling by EGFR |
| 500100 | Signal transduction by L1 |
| 500515 | EGFR downregulation |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| Cancers of the digestive system | |
| H00030 | Cervical cancer |
| Cancers of the urinary system and male genital organs | |
| H00018 | Gastric cancer |
| H00017 | Esophageal cancer |
| H00016 | Oral cancer |
| H00028 | Choriocarcinoma |
| H00022 | Bladder cancer |
| Head and neck cancers | |
| H00042 | Glioma |
| H00055 | Laryngeal cancer |
| Cancers of the breast and female genital organs | |
| Cancers of the nervous system |
| Desease ID | Desease Name |
|---|---|
| 1712 | Yersinia infection |
| 1728 | Gastrointestinal tumor |
| 1739 | Oral cancer |
| 1759 | Skin cancer |
| 1810 | Common wart |
| 1870 | Drug abuse |
| 1886 | Angiomyolipoma |
| 1893 | Esotropia |
| 1901 | Endometriosis |
| 1904 | Diabetes mellitus |
| 1933 | Papillary adenocarcinoma |
| 1934 | Cancer |
| 1936 | Hypercholesterolemia |
| 1954 | Stroke |
| 1979 | Testicular dysfunction |
| 2017 | Atopic rhinitis |
| 2042 | Thrombophlebitis |
| 2060 | Glaucoma |
| 2069 | Schizophrenia |
| 2070 | Cholelithiasis |
| 2074 | Asthma |
| 2079 | Optic atrophy |
| 2105 | Primary hyperparathyroidism |
| 2118 | Adenovirus infection |
| 2146 | Lupus erythematosus |
| 2164 | Barrett's esophagus |
| 1846 | Pleural effusion, Malignant |
| 2248 | Cytomegalovirus infection |
| Desease Name |
|---|
| polycystic kidney disease |
| Acute Coronary Syndrome |
| Cardiomyopathy, Dilated |
| colorectal cancer |
| CARDIOVASCULAR |
| anaplastic astrocytoma |
| prostate cancer |
| pancreatic cancer |
| Exanthema |
| prostatic hyperplasia |
| brain cancer |
| CANCER |
| Lung Neoplasms |
| PHARMACOGENOMIC |
| Carcinoma, Non-Small-Cell Lung |
| Asthma |
| radiation sensitivity |
| rectal cancer |
| RENAL |
| IMMUNE |
| lupus erythematosus |
| lung cancer |
| glioblastoma multiforme |
| head and neck cancer |
| No data |
| Desease Name |
|---|
| Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in |
| Nonsmall cell lung cancer, susceptibility to |
| Adenocarcinoma of lung, response to tyrosine kinase inhibitor in |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | 11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in decreased phosphorylation of EGFR protein] | decreases phosphorylation|decreases reaction | 19289568 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | 17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of EGFR protein | decreases expression | 17010675 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | 17-(allylamino)-17-demethoxygeldanamycin results in increased degradation of and results in decreased expression of EGFR protein | decreases expression|increases degradation | 16061882 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | 2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of EGFR protein | increases phosphorylation | 16778083 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | WHI P154 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16778083 |
| C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of EGFR mRNA] | affects expression|affects reaction | 19414516 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 16261397 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C484327 | 2'-benzoyloxycinnamaldehyde | 2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein | increases phosphorylation | 14660655 |
| C484327 | 2'-benzoyloxycinnamaldehyde | Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 14660655 |
| C484327 | 2'-benzoyloxycinnamaldehyde | Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 14660655 |
| C029955 | 2-nitrotoluene | 2-nitrotoluene results in decreased expression of EGFR mRNA | decreases expression | 15618236 |
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of EGFR mRNA | increases expression | 16788091 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline analog results in decreased activity of EGFR protein | decreases activity | 11822173 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16077934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16410015 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc Sulfate results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16410015 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline results in decreased activity of EGFR protein | decreases activity | 15955695 11822173 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline results in decreased activity of EGFR protein | decreases activity | 15072578 12839940 16077934 16211241 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of EGFR mRNA | increases expression | 18648102 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [AGT protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15525798 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15849355 |
| C016601 | 4-hydroxytamoxifen | EGFR protein results in decreased susceptibility to 4-hydroxytamoxifen | decreases response to substance | 18351453 |
| C017572 | 4-nitrotoluene | 4-nitrotoluene results in decreased expression of EGFR protein | decreases expression | 15618236 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of EGFR protein | increases phosphorylation | 16671086 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16671086 |
| C002202 | 4-oxoretinoic acid | 4-oxoretinoic acid results in decreased expression of EGFR mRNA | decreases expression | 15982314 |
| C105260 | 4-tert-octylphenol | 4-tert-octylphenol results in increased expression of EGFR mRNA | increases expression | 17011747 |
| C107875 | 6-(methylamino)pyrido(3,4-d)pyrimidine | 6-(methylamino)pyrido(3,4-d)pyrimidine results in decreased activity of EGFR protein | decreases activity | 15572027 |
| C469552 | A 419259 | A 419259 inhibits the reaction [GRP protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15342401 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of EGFR protein | decreases expression | 15618236 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 14660655 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 10640773 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased activity of EGFR protein] | decreases reaction|increases activity | 15520183 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17942915 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15849355 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 16261333 |
| D000171 | Acrolein | Acrolein results in increased activity of EGFR protein | increases activity | 11329622 |
| D000171 | Acrolein | Acrolein results in increased phosphorylation of EGFR protein | increases phosphorylation | 15531749 11329622 |
| D000171 | Acrolein | EGFR protein affects the reaction [Acrolein results in increased expression of MUC5AC mRNA] | affects reaction|increases expression | 15531749 |
| D000171 | Acrolein | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15531749 |
| D020106 | Acrylamide | Acrylamide analog affects the phosphorylation of EGFR protein | affects phosphorylation | 11462982 |
| D020106 | Acrylamide | Acrylamide analog results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 10753475 |
| C489254 | AEE 788 | AEE 788 results in decreased activity of EGFR protein | decreases activity | 16940797 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [SRC protein promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein]] | decreases reaction|increases phosphorylation|increases reaction | 18295415 |
| C430898 | AGN 194204 | AGN 194204 results in decreased expression of EGFR protein | decreases expression | 15318936 |
| C430898 | AGN 194204 | AGN 194204 results in decreased expression of EGFR mRNA | decreases expression | 15302862 |
| D000450 | Aldosterone | Aldosterone results in increased expression of EGFR mRNA | increases expression | 11507004 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of EGFR mRNA | decreases expression | 15982314 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17934341 |
| C005277 | alpha-naphthyl thiourea | alpha-naphthyl thiourea results in increased expression of EGFR mRNA | increases expression | 10755703 |
| D000537 | Aluminum Oxide | Aluminum Oxide results in increased expression of EGFR mRNA | increases expression | 19464052 |
| D000538 | Aluminum Silicates | Aluminum Silicates results in increased expression of EGFR protein | increases expression | 16335828 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of EGFR mRNA | affects expression | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in decreased expression of EGFR protein | decreases expression | 16483693 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in decreased expression of EGFR mRNA | decreases expression | 18332871 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in decreased expression of EGFR protein | decreases expression | 18332871 |
| D000903 | Antibiotics, Antineoplastic | EGFR protein affects the susceptibility to Antibiotics, Antineoplastic | affects response to substance | 15981280 |
| C061374 | antimonite | antimonite results in increased expression of EGFR protein | increases expression | 17400267 |
| D016718 | Arachidonic Acid | 5,8,11,14-Eicosatetraynoic Acid inhibits the reaction [Arachidonic Acid results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15525798 |
| D001151 | Arsenic | Arsenic results in increased expression of EGFR mRNA | increases expression | 19945496 |
| D001151 | Arsenic | Arsenic results in increased expression of EGFR protein alternative form | increases expression | 17453740 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of EGFR mRNA | decreases expression | 20435036 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of EGFR protein | decreases expression | 20435036 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 15961274 |
| C015001 | arsenite | arsenite results in decreased degradation of EGFR protein | decreases degradation | 17400267 |
| C015001 | arsenite | arsenite results in increased expression of EGFR protein | increases expression | 17400267 |
| C015001 | arsenite | arsenite results in increased phosphorylation of EGFR protein | increases phosphorylation | 17400267 |
| D017638 | Asbestos, Crocidolite | Acetylcysteine inhibits the reaction [Asbestos, Crocidolite results in increased activity of EGFR protein] | decreases reaction|increases activity | 15520183 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased activity of EGFR protein | increases activity | 15520183 |
| D017638 | Asbestos, Crocidolite | EGFR protein promotes the reaction [Asbestos, Crocidolite results in increased expression of FOS mRNA] | increases expression|increases reaction | 12154012 |
| D017638 | Asbestos, Crocidolite | EGFR protein promotes the reaction [Asbestos, Crocidolite results in increased expression of JUN mRNA] | increases expression|increases reaction | 12154012 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of EGFR mRNA | increases expression | 10783328 |
| D001262 | Atenolol | Atenolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16671086 |
| C065179 | atorvastatin | atorvastatin inhibits the reaction [Phenylephrine results in increased expression of and results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases expression|increases phosphorylation | 18360054 |
| D001554 | Benzene | Benzene results in decreased expression of EGFR mRNA | decreases expression | 17905399 |
| C030233 | benzo(a)pyrene-1,6-quinone | benzo(a)pyrene-1,6-quinone results in increased phosphorylation of EGFR protein | increases phosphorylation | 19166869 |
| C018003 | benzo(a)pyrene-3,6-quinone | benzo(a)pyrene-3,6-quinone results in increased phosphorylation of EGFR protein | increases phosphorylation | 19166869 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of EGFR mRNA | increases expression | 19181443 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of EGFR protein | increases phosphorylation | 19181443 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EGFR mRNA | decreases expression | 19150397 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein] | decreases reaction|increases degradation|increases phosphorylation | 17146438 |
| C002070 | betulinic acid | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16077934 |
| C002070 | betulinic acid | betulinic acid results in increased phosphorylation of EGFR protein | increases phosphorylation | 16077934 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of EGFR mRNA | decreases expression | 20678512 |
| C471992 | bosutinib | bosutinib results in decreased activity of EGFR protein | decreases activity | 18385429 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15525798 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [EGF protein binds to and results in increased degradation of EGFR protein] | affects binding|decreases reaction|increases degradation | 11134345 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [EGF protein binds to and results in increased localization of EGFR protein] | affects binding|decreases reaction|increases localization | 11134345 |
| D020122 | tert-Butylhydroperoxide | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| D020122 | tert-Butylhydroperoxide | SB 203580 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein | increases phosphorylation | 17116659 |
| D020122 | tert-Butylhydroperoxide | tyrphostin AG 1478 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of EGFR mRNA | increases expression | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of EGFR mRNA | increases expression | 18006644 16644059 |
| D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR mRNA] | decreases reaction|increases expression | 18006644 |
| C105934 | celecoxib | [celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 17908994 |
| C105934 | celecoxib | [celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein modified form | affects cotreatment|decreases expression | 17908994 |
| C105934 | celecoxib | celecoxib promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| C420268 | CI1033 | CI1033 results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 15956251 |
| C034456 | CMF regimen | EGFR protein affects the susceptibility to [Epirubicin co-treated with CMF regimen] | affects cotreatment|affects response to substance | 18768436 |
| D003474 | Curcumin | Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 10851300 15129424 18214481 |
| D003474 | Curcumin | Curcumin promotes the reaction [Folfox protocol results in decreased expression of EGFR protein] | decreases expression|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin promotes the reaction [Folfox protocol results in decreased phosphorylation of and results in decreased activity of EGFR protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin results in decreased expression of and results in decreased activity of EGFR protein | decreases activity|decreases expression | 10851300 |
| D003474 | Curcumin | Curcumin results in decreased expression of EGFR mRNA | decreases expression | 18719366 15486348 |
| D003474 | Curcumin | Curcumin results in decreased expression of EGFR protein | decreases expression | 17918158 18719366 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein | decreases activity|decreases phosphorylation | 17918158 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 15486348 |
| D003474 | Curcumin | Fluorouracil promotes the reaction [Curcumin results in decreased expression of EGFR protein] | decreases expression|increases reaction | 17918158 |
| D003474 | Curcumin | Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR mRNA] | decreases reaction|increases expression | 18006644 |
| D003474 | Curcumin | Curcumin results in decreased expression of EGFR mRNA | decreases expression | 18332871 |
| D003474 | Curcumin | Curcumin results in decreased expression of EGFR protein | decreases expression | 18332871 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 18332871 17372590 |
| D003474 | Curcumin | Curcumin results in decreased expression of EGFR | decreases expression | 18462866 |
| D003513 | Cycloheximide | Cycloheximide results in increased expression of EGFR mRNA | increases expression | 15228094 |
| D003520 | Cyclophosphamide | EGFR protein affects the susceptibility to [Cyclophosphamide co-treated with Doxorubicin co-treated with Fluorouracil] | affects cotreatment|affects response to substance | 15981280 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of EGFR mRNA | increases expression | 20106945 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGFR protein] | decreases reaction|increases expression | 8888411 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of EGFR protein] | decreases reaction|increases expression | 8888411 |
| C004742 | daidzein | [daidzein co-treated with ESR1 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| C004742 | daidzein | [daidzein co-treated with ESR1 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| C004742 | daidzein | [daidzein co-treated with ESR2 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| C004742 | daidzein | [daidzein co-treated with ESR2 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| C014347 | decitabine | decitabine results in increased expression of EGFR mRNA | increases expression | 19151715 |
| C107676 | deguelin | deguelin metabolite results in decreased expression of EGFR protein | decreases expression | 19139008 |
| C107676 | deguelin | deguelin results in decreased expression of EGFR protein | decreases expression | 19139008 |
| D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased activity of EGFR protein | increases activity | 16213893 |
| D003840 | Deoxycholic Acid | EGFR protein results in decreased susceptibility to Deoxycholic Acid | decreases response to substance | 12507930 |
| D003907 | Dexamethasone | Dexamethasone results in decreased phosphorylation of and results in decreased activity of EGFR protein | decreases activity|decreases phosphorylation | 15556944 |
| D002945 | Cisplatin | [Cisplatin co-treated with Fluorouracil] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 15737843 |
| D002945 | Cisplatin | EGFR mRNA results in decreased susceptibility to Cisplatin | decreases response to substance | 18337622 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of EGFR mRNA | decreases expression | 15238619 |
| D004052 | Diethylnitrosamine | Acetylcysteine inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17942915 |
| D004052 | Diethylnitrosamine | CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of EGFR protein] | decreases expression|increases reaction | 20583210 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 20101389 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of EGFR protein | decreases expression | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 17942915 |
| D004052 | Diethylnitrosamine | MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17942915 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of EGFR mRNA | decreases expression | 19638242 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of EGFR mRNA | increases expression | 17011747 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 16391241 |
| C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 16261333 |
| D004177 | Dipyrone | Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| D004280 | Dobutamine | EGFR gene mutant form results in decreased susceptibility to Dobutamine | decreases response to substance | 18599591 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of EGFR protein | increases phosphorylation | 17974986 |
| D004317 | Doxorubicin | EGFR protein affects the susceptibility to [Cyclophosphamide co-treated with Doxorubicin co-treated with Fluorouracil] | affects cotreatment|affects response to substance | 15981280 |
| D004317 | Doxorubicin | [[gefitinib results in decreased activity of EGFR protein] which affects the localization of ABCG2 protein] which results in decreased export of Doxorubicin | affects localization|decreases activity|decreases export | 17938326 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of EGFR protein | increases phosphorylation | 17974986 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 15843167 |
| D015117 | 5,8,11,14-Eicosatetraynoic Acid | 5,8,11,14-Eicosatetraynoic Acid inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15525798 |
| D015117 | 5,8,11,14-Eicosatetraynoic Acid | 5,8,11,14-Eicosatetraynoic Acid inhibits the reaction [Arachidonic Acid results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15525798 |
| D015251 | Epirubicin | EGFR protein affects the susceptibility to [Epirubicin co-treated with CMF regimen] | affects cotreatment|affects response to substance | 18768436 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [EGF protein binds to EGFR protein] | affects binding|decreases reaction | 17616711 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to EGFR protein]] | affects binding|decreases reaction|increases reaction | 17616711 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17616711 |
| C400278 | erlotinib | erlotinib inhibits the reaction [sodium arsenite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 19168569 |
| C400278 | erlotinib | erlotinib results in decreased activity of EGFR protein | decreases activity | 12907618 |
| C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in increased expression of EGFR protein | increases expression | 15778002 |
| D004958 | Estradiol | EGF protein inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18629630 |
| D004958 | Estradiol | EGF protein inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 protein] | affects cotreatment|decreases reaction|increases expression | 18629630 |
| D004958 | Estradiol | EGF protein promotes the reaction [Estradiol results in increased phosphorylation of EGFR protein] | increases phosphorylation|increases reaction | 20005069 |
| D004958 | Estradiol | [Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 mRNA | affects cotreatment|increases expression | 18629630 |
| D004958 | Estradiol | [Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 protein | affects cotreatment|increases expression | 18629630 |
| D004958 | Estradiol | [Estradiol co-treated with ESR1 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| D004958 | Estradiol | [Estradiol co-treated with ESR1 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| D004958 | Estradiol | [Estradiol co-treated with ESR2 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| D004958 | Estradiol | [Estradiol co-treated with ESR2 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19619570 |
| D004958 | Estradiol | Estradiol results in decreased expression of EGFR mRNA | decreases expression | 20005069 |
| D004958 | Estradiol | Estradiol results in decreased expression of EGFR protein | decreases expression | 20005069 |
| D004958 | Estradiol | Estradiol results in increased expression of EGFR mRNA | increases expression | 19619570 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of EGFR protein | increases phosphorylation | 20005069 |
| D004958 | Estradiol | ICI 164384 inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18629630 |
| D004958 | Estradiol | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGFR protein] | decreases reaction|increases expression | 8888411 |
| D004958 | Estradiol | Estradiol results in decreased expression of EGFR mRNA | decreases expression | 20068009 |
| D004958 | Estradiol | Estradiol results in increased expression of EGFR protein | increases expression | 8888411 |
| D004967 | Estrogens | Estrogens results in increased expression of EGFR mRNA | increases expression | 14647453 |
| D000431 | Ethanol | Ethanol results in increased expression of EGFR mRNA | increases expression | 15353170 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of EGFR mRNA | affects expression | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of EGFR mRNA | increases expression | 17942748 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of EGFR gene | increases mutagenesis | 15366372 16724327 |
| D005047 | Etoposide | Etoposide results in decreased expression of EGFR mRNA | decreases expression | 15228094 |
| D005047 | Etoposide | Etoposide results in decreased expression of EGFR protein | decreases expression | 15228094 |
| D005054 | Eugenol | Eugenol results in decreased expression of EGFR protein | decreases expression | 15618236 |
| D005054 | Eugenol | Eugenol results in increased expression of EGFR mRNA | increases expression | 15618236 |
| D011345 | Fenofibrate | Fenofibrate results in decreased expression of EGFR mRNA | decreases expression | 11798191 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene affects the reaction [EGF protein results in increased phosphorylation of EGFR protein] | affects reaction|increases phosphorylation | 10900465 |
| D005472 | Fluorouracil | [Cisplatin co-treated with Fluorouracil] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 15737843 |
| D005472 | Fluorouracil | EGFR gene polymorphism affects the susceptibility to [oxaliplatin co-treated with Fluorouracil] | affects cotreatment|affects response to substance | 16098254 |
| D005472 | Fluorouracil | EGFR gene polymorphism results in decreased susceptibility to Fluorouracil | decreases response to substance | 19217205 |
| D005472 | Fluorouracil | EGFR protein affects the susceptibility to [Cyclophosphamide co-treated with Doxorubicin co-treated with Fluorouracil] | affects cotreatment|affects response to substance | 15981280 |
| D005472 | Fluorouracil | EGFR protein affects the susceptibility to Fluorouracil | affects response to substance | 17169374 16836928 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [Curcumin results in decreased expression of EGFR protein] | decreases expression|increases reaction | 17918158 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [Curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of EGFR protein | decreases expression | 17982676 17918158 |
| D005472 | Fluorouracil | Fluorouracil results in decreased phosphorylation of and results in decreased activity of EGFR protein | decreases activity|decreases phosphorylation | 17918158 |
| D005472 | Fluorouracil | Fluorouracil results in increased phosphorylation of EGFR protein | increases phosphorylation | 18794807 |
| D005472 | Fluorouracil | TP53 protein affects the reaction [Fluorouracil results in decreased expression of EGFR protein] | affects reaction|decreases expression | 17982676 |
| C410216 | Folfox protocol | Curcumin promotes the reaction [Folfox protocol results in decreased expression of EGFR protein] | decreases expression|increases reaction | 17918158 |
| C410216 | Folfox protocol | Curcumin promotes the reaction [Folfox protocol results in decreased phosphorylation of and results in decreased activity of EGFR protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| C410216 | Folfox protocol | Folfox protocol results in decreased expression of EGFR protein | decreases expression | 17918158 |
| C410216 | Folfox protocol | Folfox protocol results in decreased phosphorylation of and results in decreased activity of EGFR protein | decreases activity|decreases phosphorylation | 17918158 |
| D005620 | Freund's Adjuvant | [Urethane co-treated with Freund's Adjuvant] results in increased expression of EGFR mRNA | affects cotreatment|increases expression | 12400877 |
| C106014 | gedunin | gedunin results in decreased expression of EGFR protein | decreases expression | 17010675 |
| C419708 | gefitinib | EGFR gene polymorphism results in increased susceptibility to gefitinib | increases response to substance | 18625569 |
| C419708 | gefitinib | EGFR protein affects the susceptibility to gefitinib | affects response to substance | 15976335 16243822 |
| C419708 | gefitinib | EGFR protein mutant form results in decreased susceptibility to gefitinib | decreases response to substance | 17290066 |
| C419708 | gefitinib | gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17898861 |
| C419708 | gefitinib | gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16243822 |
| C419708 | gefitinib | gefitinib inhibits the reaction [gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein] | decreases reaction|increases degradation|increases phosphorylation | 17146438 |
| C419708 | gefitinib | gefitinib inhibits the reaction [irinotecan metabolite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15723263 |
| C419708 | gefitinib | gefitinib inhibits the reaction [irinotecan results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15723263 |
| C419708 | gefitinib | gefitinib results in decreased activity of EGFR protein | decreases activity | 20549698 17938326 |
| C419708 | gefitinib | gefitinib results in decreased activity of [EGFR protein binds to EGFR protein] | affects binding|decreases activity | 17898861 |
| C419708 | gefitinib | gefitinib results in decreased activity of [EGFR protein binds to ERBB2 protein] | affects binding|decreases activity | 17898861 |
| C419708 | gefitinib | [gefitinib results in decreased activity of EGFR protein] which affects the localization of ABCG2 protein | affects localization|decreases activity | 17938326 |
| C419708 | gefitinib | [[gefitinib results in decreased activity of EGFR protein] which affects the localization of ABCG2 protein] which results in decreased export of Doxorubicin | affects localization|decreases activity|decreases export | 17938326 |
| C419708 | gefitinib | gefitinib results in decreased expression of EGFR protein modified form | decreases expression | 19288272 |
| C419708 | gefitinib | gefitinib results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 18375820 |
| C419708 | gefitinib | gefitinib results in decreased activity of EGFR protein | decreases activity | 15651060 15735670 16261397 |
| C056507 | gemcitabine | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein] | decreases reaction|increases degradation|increases phosphorylation | 17146438 |
| C056507 | gemcitabine | gefitinib inhibits the reaction [gemcitabine results in increased phosphorylation of and results in increased degradation of EGFR protein] | decreases reaction|increases degradation|increases phosphorylation | 17146438 |
| C056507 | gemcitabine | gemcitabine results in decreased expression of EGFR protein | decreases expression | 17146438 |
| C056507 | gemcitabine | gemcitabine results in increased degradation of EGFR protein | increases degradation | 17146438 |
| C056507 | gemcitabine | gemcitabine results in increased expression of EGFR mRNA | increases expression | 17146438 |
| C056507 | gemcitabine | gemcitabine results in increased phosphorylation of EGFR protein | increases phosphorylation | 17146438 |
| D019833 | Genistein | [Genistein co-treated with ESR1 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| D019833 | Genistein | [Genistein co-treated with ESR1 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| D019833 | Genistein | [Genistein co-treated with ESR2 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| D019833 | Genistein | [Genistein co-treated with ESR2 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| D019833 | Genistein | Genistein results in decreased expression of EGFR mRNA | decreases expression | 15257099 |
| D019833 | Genistein | Genistein results in decreased expression of EGFR mRNA | decreases expression | 11880592 |
| D019833 | Genistein | Genistein results in increased expression of EGFR protein | increases expression | 15781664 |
| D005978 | Glutathione | Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 14660655 |
| C078131 | GM 6001 | GM 6001 inhibits the reaction [Asbestos, Serpentine results in increased activity of EGFR protein] | decreases reaction|increases activity | 16571779 |
| C078131 | GM 6001 | GM 6001 affects the reaction [PTPN11 protein affects the reaction [EDN1 protein results in increased phosphorylation of and results in increased activity of EGFR protein]] | affects reaction|increases activity|increases phosphorylation | 16261333 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [EGF protein binds to and results in increased localization of EGFR protein] | affects binding|decreases reaction|increases localization | 11134345 |
| D006581 | Hexachlorobenzene | AG 1879 inhibits the reaction [SRC protein promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein]] | decreases reaction|increases phosphorylation|increases reaction | 18295415 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein] | affects binding|increases reaction | 18295415 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased phosphorylation of EGFR protein | increases phosphorylation | 18295415 |
| D006581 | Hexachlorobenzene | SRC protein promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein] | increases phosphorylation|increases reaction | 18295415 |
| D017313 | Fenretinide | Fenretinide results in increased expression of EGFR mRNA | increases expression | 16570282 |
| D006851 | Hydrochloric Acid | celecoxib promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| D006851 | Hydrochloric Acid | Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of EGFR protein | increases expression | 15309881 |
| D006851 | Hydrochloric Acid | Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| D006861 | Hydrogen Peroxide | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 10640773 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 10640773 |
| C051781 | ICI 164384 | ICI 164384 inhibits the reaction [[Estradiol co-treated with EGFR protein] results in increased expression of SIAH2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18629630 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in decreased expression of EGFR protein | decreases expression | 18025290 |
| D007213 | Indomethacin | Indomethacin results in increased expression of EGFR protein | increases expression | 17977527 |
| D007213 | Indomethacin | malabaricone B promotes the reaction [Indomethacin results in increased expression of EGFR protein] | increases expression|increases reaction | 17977527 |
| D007213 | Indomethacin | malabaricone C promotes the reaction [Indomethacin results in increased expression of EGFR protein] | increases expression|increases reaction | 17977527 |
| C051890 | irinotecan | bisindolylmaleimide I inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | bisindolylmaleimide I inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | gefitinib inhibits the reaction [irinotecan metabolite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15723263 |
| C051890 | irinotecan | gefitinib inhibits the reaction [irinotecan results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15723263 |
| C051890 | irinotecan | Go 6976 inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | Go 6976 inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | irinotecan metabolite results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 15723263 |
| C051890 | irinotecan | irinotecan results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 15723263 |
| C051890 | irinotecan | rottlerin inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | rottlerin inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C051890 | irinotecan | irinotecan metabolite results in decreased activity of EGFR protein | decreases activity | 15723263 |
| C051890 | irinotecan | irinotecan results in decreased activity of EGFR protein | decreases activity | 15723263 |
| C107086 | KB R7785 | KB R7785 inhibits the reaction [IL1B protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15300588 |
| C107086 | KB R7785 | KB R7785 inhibits the reaction [IL8 protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15300588 |
| C107086 | KB R7785 | KB R7785 results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 16240219 |
| C490728 | lapatinib | lapatinib results in decreased activity of EGFR protein | decreases activity | 15665275 20549698 |
| C490728 | lapatinib | lapatinib results in decreased activity of EGFR protein | decreases activity | 16091755 |
| D007854 | Lead | Lead results in decreased expression of EGFR protein | decreases expression | 17298174 |
| C008261 | lead acetate | lead acetate results in decreased expression of EGFR protein | decreases expression | 17298174 |
| D008044 | Linuron | Linuron results in decreased expression of EGFR mRNA | decreases expression | 12730624 |
| D017997 | Leukotriene C4 | Leukotriene C4 results in increased expression of EGFR mRNA | increases expression | 12388339 |
| D047311 | Luteolin | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15135307 |
| D047311 | Luteolin | Luteolin results in decreased phosphorylation of and results in increased activity of EGFR protein | decreases phosphorylation|increases activity | 15135307 |
| C071788 | malabaricone B | malabaricone B promotes the reaction [Indomethacin results in increased expression of EGFR protein] | increases expression|increases reaction | 17977527 |
| C071787 | malabaricone C | malabaricone C promotes the reaction [Indomethacin results in increased expression of EGFR protein] | increases expression|increases reaction | 17977527 |
| D008731 | Methoxychlor | Dactinomycin inhibits the reaction [Methoxychlor results in increased expression of EGFR protein] | decreases reaction|increases expression | 8888411 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of EGFR protein | increases expression | 8888411 |
| C005223 | methyleugenol | methyleugenol results in decreased expression of EGFR protein | decreases expression | 15618236 |
| C002950 | methylformamide | methylformamide analog results in decreased expression of EGFR mRNA | decreases expression | 17040096 |
| C002950 | methylformamide | methylformamide results in decreased expression of EGFR mRNA | decreases expression | 17040096 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of EGFR protein | decreases expression | 17298174 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of EGFR protein | decreases expression | 17298174 |
| D015741 | Metribolone | Metribolone results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 17272394 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of EGFR mRNA | increases expression | 19945496 |
| C092152 | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide | N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [ELANE protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17456367 |
| C415243 | N-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)acrylamide | N-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)acrylamide results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 10987266 |
| C465666 | N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide | N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide binds to and results in decreased phosphorylation of EGFR protein | affects binding|decreases phosphorylation | 12209961 |
| C465666 | N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide | N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 12573320 |
| C452423 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in decreased activity of EGFR protein | decreases activity | 17431108 16940797 |
| D019829 | Nevirapine | Nevirapine results in decreased expression of EGFR mRNA | decreases expression | 19152342 |
| C029938 | nickel sulfate | [TGFA protein binds to and affects the activity of EGFR protein] which results in decreased susceptibility to nickel sulfate | affects activity|affects binding|decreases response to substance | 19131640 |
| C510003 | nordy | nordy inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17377739 |
| C042763 | olive oil | olive oil analog affects the expression of EGFR mRNA | affects expression | 17349074 |
| D010047 | Ovalbumin | Ovalbumin results in increased expression of EGFR mRNA | increases expression | 12388339 |
| C030110 | oxaliplatin | EGFR gene polymorphism affects the susceptibility to [oxaliplatin co-treated with Fluorouracil] | affects cotreatment|affects response to substance | 16098254 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of EGFR protein | increases phosphorylation | 16243822 |
| D010076 | Oxazepam | Oxazepam results in decreased expression of EGFR mRNA | decreases expression | 15618236 |
| D010076 | Oxazepam | Oxazepam results in decreased expression of EGFR protein | decreases expression | 15618236 |
| C029341 | oxophenylarsine | oxophenylarsine inhibits the reaction [EGF protein binds to and affects the localization of EGFR protein] | affects binding|affects localization|decreases reaction | 12093727 |
| D010126 | Ozone | AHR protein affects the reaction [Ozone results in increased phosphorylation of EGFR protein] | affects reaction|increases phosphorylation | 19536146 |
| D010126 | Ozone | Ozone results in increased phosphorylation of EGFR protein | increases phosphorylation | 19536146 |
| D017239 | Paclitaxel | Paclitaxel results in increased phosphorylation of EGFR protein | increases phosphorylation | 16211241 |
| D017239 | Paclitaxel | [PD168393 co-treated with Paclitaxel] results in decreased phosphorylation of EGFR protein | affects cotreatment|decreases phosphorylation | 16413505 |
| D010269 | Paraquat | Paraquat results in decreased expression of EGFR protein | decreases expression | 17298174 |
| C509204 | PD168393 | [PD168393 co-treated with Paclitaxel] results in decreased phosphorylation of EGFR protein | affects cotreatment|decreases phosphorylation | 16413505 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [EGFR protein binds to GPR30 protein] | affects binding|decreases reaction | 19749156 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of EGFR mRNA | decreases expression | 18332871 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of EGFR protein | decreases expression | 18332871 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of EGFR mRNA | decreases expression | 16221955 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of EGFR mRNA] | affects reaction|decreases expression | 19482888 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of EGFR mRNA | affects expression | 19136022 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of EGFR mRNA | decreases expression | 19482888 |
| D010656 | Phenylephrine | atorvastatin inhibits the reaction [Phenylephrine results in increased expression of and results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases expression|increases phosphorylation | 18360054 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of and results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases expression|increases phosphorylation | 18360054 |
| D010656 | Phenylephrine | [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | affects binding|increases phosphorylation|increases reaction | 16760267 |
| D010656 | Phenylephrine | [EGF protein binds to EGFR protein] promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] | affects binding|increases phosphorylation|increases reaction | 16760267 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of EGFR protein | increases phosphorylation | 14676212 |
| C008890 | phosphoramidon | phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D010882 | Piperonyl Butoxide | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 20101389 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of EGFR mRNA | affects expression | 19136022 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EGFR mRNA | affects binding|decreases expression|increases activity | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of EGFR mRNA | decreases expression | 11798191 20059764 17426115 15302862 18445702 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of EGFR mRNA] | decreases expression|increases reaction | 20059764 |
| D010894 | Piroxicam | Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] | increases expression|increases reaction | 15309881 |
| D011374 | Progesterone | Progesterone promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] | increases phosphorylation|increases reaction | 16175315 |
| D011374 | Progesterone | Progesterone results in increased expression of EGFR protein | increases expression | 16175315 |
| D015232 | Dinoprostone | Dinoprostone results in increased phosphorylation of EGFR protein | increases phosphorylation | 17805209 |
| D015232 | Dinoprostone | EGFR protein results in increased secretion of Dinoprostone | increases secretion | 16213893 |
| D011794 | Quercetin | Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15135307 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of and results in increased activity of EGFR protein | decreases phosphorylation|increases activity | 15135307 |
| D011799 | Quinazolines | Quinazolines analog results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 10753475 |
| C059514 | resveratrol | resveratrol promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] | increases phosphorylation|increases reaction | 16343977 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of EGFR mRNA | decreases expression | 15982314 |
| D012402 | Rotenone | Rotenone results in decreased expression of EGFR protein | decreases expression | 17555550 |
| C085746 | rottlerin | rottlerin inhibits the reaction [irinotecan metabolite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C085746 | rottlerin | rottlerin inhibits the reaction [irinotecan results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15723263 |
| C085746 | rottlerin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| C090142 | secoisolariciresinol diglucoside | secoisolariciresinol diglucoside results in decreased expression of EGFR mRNA | decreases expression | 19904759 |
| D012643 | Selenium | Selenium results in decreased expression of EGFR mRNA | decreases expression | 17390030 |
| D012645 | Selenomethionine | Selenomethionine results in increased expression of EGFR mRNA | increases expression | 17205524 |
| D017632 | Asbestos, Serpentine | Asbestos, Serpentine results in increased activity of EGFR protein | increases activity | 16571779 |
| D017632 | Asbestos, Serpentine | GM 6001 inhibits the reaction [Asbestos, Serpentine results in increased activity of EGFR protein] | decreases reaction|increases activity | 16571779 |
| C017947 | sodium arsenite | erlotinib inhibits the reaction [sodium arsenite results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 19168569 |
| C017947 | sodium arsenite | sodium arsenite results in increased activity of EGFR protein | increases activity | 19414066 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of EGFR mRNA | increases expression | 12016162 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 19168569 15504454 11723127 |
| C017947 | sodium arsenite | SU 6656 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C017947 | sodium arsenite | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of EGFR mRNA | affects expression | 16507464 |
| C017947 | sodium arsenite | sodium arsenite promotes the reaction [SRC protein binds to EGFR protein] | affects binding|increases reaction | 11723127 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of EGFR mRNA | decreases expression | 19822182 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of EGFR protein | decreases expression | 16507464 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of EGFR mRNA | increases expression | 17077188 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 11723127 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C416927 | SU 6656 | SU 6656 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C025463 | sulindac sulfone | [celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 17908994 |
| C025463 | sulindac sulfone | [celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein modified form | affects cotreatment|decreases expression | 17908994 |
| D013629 | Tamoxifen | EGFR protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 16000581 15665275 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19347870 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of EGFR protein | affects cotreatment|decreases expression | 19347870 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR mRNA | affects cotreatment|increases expression | 19347870 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of EGFR protein | affects cotreatment|increases expression | 19347870 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of EGFR mRNA | increases expression | 20005069 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of EGFR protein | increases expression | 20005069 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of EGFR mRNA | affects expression | 17555576 |
| D016593 | Terfenadine | 11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in decreased phosphorylation of EGFR protein] | decreases phosphorylation|decreases reaction | 19289568 |
| D016593 | Terfenadine | Terfenadine analog results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 19289568 |
| D013739 | Testosterone | Testosterone results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 17272394 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17934341 |
| D013749 | Tetrachlorodibenzodioxin | EGFR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | increases activity|increases phosphorylation|increases reaction | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | EGFR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | EGFR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of MAPK3 protein] | increases activity|increases phosphorylation|increases reaction | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EGFR mRNA | affects cotreatment|decreases expression | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of EGFR mRNA | increases expression | 19619570 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 17934341 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of EGFR mRNA | decreases expression | 14708085 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of EGFR mRNA | increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of EGFR protein | increases phosphorylation | 8470122 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of and affects the localization of EGFR protein | affects localization|decreases expression | 11752688 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of EGFR protein | increases phosphorylation | 15592923 |
| D014051 | Toluene 2,4-Diisocyanate | EGFR protein affects the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|affects reaction|increases expression | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | EGFR protein affects the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein] | affects binding|affects reaction|increases expression | 16908450 |
| D014051 | Toluene 2,4-Diisocyanate | EGFR protein affects the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of IL8 protein] | affects binding|affects reaction|increases expression | 16908450 |
| D014212 | Tretinoin | Tretinoin metabolite results in decreased expression of EGFR mRNA | decreases expression | 15982314 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of EGFR protein | decreases expression | 16473924 15970678 |
| D014212 | Tretinoin | HBEGF protein promotes the reaction [Tretinoin results in increased phosphorylation of EGFR protein] | increases phosphorylation|increases reaction | 16357442 |
| D014212 | Tretinoin | Tretinoin results in increased expression of EGFR mRNA | increases expression | 16604517 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of EGFR protein | increases phosphorylation | 16357442 |
| C050414 | tripterine | tripterine results in decreased expression of EGFR protein | decreases expression | 17010675 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15531749 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16472761 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGFR protein binds to GPR30 protein] | affects binding|decreases reaction | 19749156 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15504454 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased phosphorylation of EGFR protein | decreases phosphorylation | 18633435 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased activity of EGFR protein | decreases activity | 12794006 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 17116659 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15849355 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGFR protein affects the reaction [EDN1 protein results in increased phosphorylation of MAPK1 protein]] | affects reaction|decreases reaction|increases phosphorylation | 16261333 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGFR protein affects the reaction [EDN1 protein results in increased phosphorylation of MAPK3 protein]] | affects reaction|decreases reaction|increases phosphorylation | 16261333 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [LHB protein results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 15459120 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased activity of EGFR protein | decreases activity | 15574683 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 results in decreased activity of EGFR protein | decreases activity | 15706222 16391241 16373414 15279711 |
| C113580 | U 0126 | U 0126 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of EGFR mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | [Urethane co-treated with Freund's Adjuvant] results in increased expression of EGFR mRNA | affects cotreatment|increases expression | 12400877 |
| D014520 | Urethane | Urethane results in increased expression of EGFR mRNA | increases expression | 12400877 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate results in increased phosphorylation of EGFR protein | increases phosphorylation | 14676212 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of EGFR mRNA | decreases expression | 19244175 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased phosphorylation of EGFR protein | increases phosphorylation | 15843167 |
| C113888 | WHI P154 | WHI P154 inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16778083 |
| C009687 | wortmannin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D015032 | Zinc | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16410015 |
| D015032 | Zinc | Zinc results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 16410015 |
| D019287 | Zinc Sulfate | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Zinc Sulfate results in increased phosphorylation of EGFR protein] | decreases reaction|increases phosphorylation | 16410015 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased phosphorylation of and results in increased activity of EGFR protein | increases activity|increases phosphorylation | 16410015 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.36 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 11.03 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 11.03 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 11.03 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 11.03 | 14514962 15322242 11752688 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 3.90 | 18769834 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 16.00 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 16.00 | 11192467 | |
| MESH:D000138 | Acidosis | Hydrochloric Acid | 16.00 | 19262391 11574821 15920416 20872349 12771618 16144966 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 16.00 | 7265320 | |
| MESH:D000141 | Acidosis, Renal Tubular | Hydrochloric Acid | 4.62 | 17183249 | |
| MESH:D000142 | Acidosis, Respiratory | Hydrochloric Acid | 4.62 | 20597076 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 5.09 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 8.06 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 8.06 | 16185265 18769834 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.33 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 4.23 | 17190629 17202136 16889938 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 5.35 | 12690470 15814532 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 5.35 | 16538975 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 12.94 | 21297076 20525806 | |
| MESH:D055371 | Acute Lung Injury | Hydrochloric Acid | 12.94 | 19060228 11850527 11953099 19760209 19094174 16759491 15970105 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 12.94 | 12718980 16100012 11954676 19131640 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 12.94 | 18653653 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 27.50 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 27.50 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 27.50 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 27.50 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 27.50 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 27.50 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 27.50 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 27.50 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 27.50 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 27.50 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 27.50 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 27.50 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.52 | 15814487 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 26.48 | 10737359 | |
| MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 26.48 | 3712494 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 26.48 | 16176798 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 26.48 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 26.48 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Ethylnitrosourea | 26.48 | 6695378 | |
| MESH:D000236 | Adenoma | Indomethacin | 26.48 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 26.48 | 15688382 | |
| MESH:D000236 | Adenoma | Urethane | 26.48 | 16926031 10530776 6695378 17093202 10822126 11497255 17195641 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.81 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 15.40 | 17162532 19052882 16434500 19061943 18056438 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 15.40 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 15.40 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 15.40 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 10.50 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 10.50 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 10.50 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.51 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.84 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.84 | 17306315 16712894 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 2.65 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.41 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.12 | 15451039 15451040 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.89 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | Terfenadine | 4.57 | 16037679 | |
| MESH:D000505 | Alopecia | Tretinoin | 2.62 | 15955085 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.18 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 9.54 | 17570602 14715435 15207723 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 9.54 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 9.54 | 17627676 15579461 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 9.54 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 9.54 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 9.54 | 16580781 17119284 16410023 16325427 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.35 | 15469931 | |
| MESH:D000740 | Anemia | Fluorouracil | 5.19 | 15504547 16511603 17963324 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 5.19 | 11748828 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.38 | 11369114 14761424 17661222 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.16 | 17084956 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.77 | 16916123 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.66 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.67 | 15513904 | |
| MESH:D000860 | Anoxia | Hydrochloric Acid | 7.74 | 15090967 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 7.74 | 7265320 | |
| MESH:D000987 | Antisocial Personality Disorder | Testosterone | 4.66 | 7506515 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 3.02 | 11141031 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 8.46 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 8.46 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 13.52 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 13.52 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 13.52 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 3.08 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.39 | 12569548 16251483 16835338 18414634 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 15.11 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 15.11 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 15.11 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 15.11 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.98 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 10.45 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 10.45 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 10.45 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 10.45 | 16412693 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 6.50 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 6.50 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 6.50 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.50 | 16292516 | |
| MESH:D001195 | Asbestosis | Asbestos, Serpentine | 4.54 | 10751356 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 8.84 | 16516891 | |
| MESH:D001249 | Asthma | Ozone | 8.84 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 8.84 | 15590891 11467998 7684630 10797510 10934080 6091945 17015710 19187332 18394133 12684321 3040596 12585506 170078 11742282 15590890 6091946 15855793 16210060 16792590 12762349 20032816 11077013 8156442 | |
| MESH:D001249 | Asthma | Tretinoin | 8.84 | 16456186 | |
| MESH:D001249 | Asthma | Zinc | 8.84 | 17085522 | |
| MESH:D001259 | Ataxia | 1-Butanol | 4.48 | 7820390 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.80 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 11.72 | 16126721 16037261 17363696 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 11.72 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 11.72 | 18704882 | |
| MESH:D050197 | Atherosclerosis | olive oil | 11.72 | 16216721 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 11.72 | 17967414 16873680 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.15 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 2.15 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 2.15 | 19056591 18929414 16917939 19267885 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 11.59 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 11.59 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 11.59 | 19761891 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.27 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 8.88 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 8.88 | 10684365 | |
| MESH:D001650 | Bile Duct Neoplasms | therapeutic | 17341899 | ||
| MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 3.82 | 11289319 1440618 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 17.56 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Hydrochloric Acid | 17.56 | 15920416 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 17.56 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 17.56 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 17.56 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.60 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.89 | 15746008 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 4.04 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 19.68 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 19.68 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 19.68 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 19.68 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 3.47 | 15867366 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 6.38 | 11985600 | |
| MESH:D001862 | Bone Resorption | Freund's Adjuvant | 6.38 | 16769263 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 3.39 | 15306635 | |
| MESH:D001927 | Brain Diseases | Ethylnitrosourea | 3.81 | 14991843 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.84 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.14 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 7.24 | 15845082 15380490 15665606 | |
| MESH:D001930 | Brain Injuries | Zinc | 7.24 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 10.42 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 10.42 | 12524144 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 10.42 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 12.33 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 12.33 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Ethylnitrosourea | 12.33 | 16651633 15144691 16436596 16357521 18412241 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 12.33 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 18768436 19075277 20135347 16950593 | ||
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 49.18 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | Acrylamide | 49.18 | 16253758 18183576 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 49.18 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 49.18 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 49.18 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 49.18 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | CI1033 | 49.18 | 15956251 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 49.18 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | CMF regimen | 49.18 | 17145825 16234514 15668708 19151563 19115204 12006526 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 49.18 | 18593918 18462866 19250217 16243823 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 49.18 | 17020986 11325840 17388661 12006526 18234424 16978400 15136595 18323546 15093573 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 49.18 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 49.18 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 49.18 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 49.18 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 49.18 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 49.18 | 15136595 16322301 16096432 17426702 18695136 15567936 19526202 15939500 16264153 17983394 11325840 16935488 18628466 15994142 18234424 17369602 15668708 16115903 16826403 16595493 15993339 15692762 18382427 15634643 | |
| MESH:D001943 | Breast Neoplasms | Epirubicin | 49.18 | 12006526 15093573 17388661 18511948 16642371 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 49.18 | 12948864 17289903 16675129 17261762 18497071 17018787 14630087 19861407 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 49.18 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 49.18 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 49.18 | 16557594 16595493 16110121 15136595 18608205 19217205 18357371 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 49.18 | 17039268 18382427 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 49.18 | 17200150 16541309 16873071 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 49.18 | 15061365 12709520 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 49.18 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 49.18 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | lapatinib | 49.18 | 16091755 | |
| MESH:D001943 | Breast Neoplasms | methyleugenol | 49.18 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 49.18 | 15136595 18234424 16115903 18323546 11325840 16273361 18223236 16244791 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 49.18 | 16175315 17614352 15562024 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 49.18 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 49.18 | 17651959 16393696 17534123 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 49.18 | 19084267 19066611 19189212 18984771 19115204 18855134 19189210 18425577 19155303 18997820 18815881 19289846 16202921 20005174 15668708 18821012 15565566 18351453 19142967 16818667 20135344 20065188 17261762 21138602 19011961 16273361 19221464 19410462 21152245 19103187 17893378 20859285 11161223 19244106 19200415 17242785 18629630 19059307 20390343 19288272 20544844 17440819 19487384 17049068 16873071 | |
| MESH:D001943 | Breast Neoplasms | Testosterone | 49.18 | 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 49.18 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 49.18 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 49.18 | 16873071 16443354 16166294 | |
| MESH:D016535 | Bronchial Hyperreactivity | Hydrochloric Acid | 20.12 | 12378975 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene C4 | 20.12 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ovalbumin | 20.12 | 12794006 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 20.12 | 15516495 19059883 18417511 14754758 18315731 17626835 16777450 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 20.12 | 15590891 8156442 12507178 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 20.12 | 12794006 | |
| MESH:D001986 | Bronchial Spasm | Hydrochloric Acid | 4.28 | 15578804 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.42 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.22 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 7.57 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 7.57 | 10459503 | |
| MESH:D002100 | Cachexia | Indomethacin | 8.51 | 15625704 16537180 11239499 15141370 | |
| MESH:D002100 | Cachexia | Ozone | 8.51 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.35 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.29 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 6.15 | 3786805 16124888 10355542 16011737 15700767 18705752 16227642 16192424 15673190 16050911 15721981 16097048 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 6.15 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 8.41 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 8.41 | 16051944 | |
| MESH:D002277 | Carcinoma | marker/mechanism | 15302576 | ||
| MESH:D002277 | Carcinoma | Curcumin | 8.23 | 18593918 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 8.23 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 8.23 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.78 | 17687452 15504454 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.35 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.96 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 9029167 | ||
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 62.61 | 3084413 17761372 10737359 3581430 6705139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 62.61 | 3581430 7296757 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 62.61 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 62.61 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 62.61 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 62.61 | 11135700 15073043 14691202 15553829 16217749 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 62.61 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 62.61 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 62.61 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 62.61 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 62.61 | 17761372 20512989 19171122 18691550 17428255 3581430 17138121 16779866 17173139 19418558 20935162 20101231 17978847 16830150 16288022 16502159 18785209 19208518 16569478 19335982 18210153 19519916 19052882 19394651 18393292 18978308 3084413 18494052 16878318 20007298 16935385 17162532 18788625 16698587 19701751 21159647 20727157 19107877 20514400 18665156 19539802 20084675 10672840 20524982 19919837 16540662 20214788 16328049 18506893 19383236 17055752 16807293 16681979 18971187 19822196 11831363 20432363 18056438 10737359 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 62.61 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 62.61 | 18059187 16234567 17876044 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 62.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 62.61 | 15341023 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 62.61 | 18788625 15763234 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 62.61 | 17159502 16270382 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 62.61 | 17088986 17971768 16332177 16799960 17045692 18930000 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 62.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 62.61 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 62.61 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 62.61 | 1701930 6705139 20007298 20935162 17173139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 62.61 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 62.61 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 62.61 | 15276417 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 62.61 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 62.61 | 1917145 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.81 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 12.38 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 12.38 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 12.38 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.17 | 14736730 18791128 11352223 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | CI1033 | 13.03 | 15956251 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 13.03 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 13.03 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | erlotinib | 13.03 | 17290066 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 13.03 | 15496427 20005069 17290066 16230376 18347146 19233551 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 13.03 | 18758305 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.80 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.68 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 15.69 | 7296757 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 15.69 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 15.69 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 15.69 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 15.69 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 15.69 | 17341418 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.05 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 45.80 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 45.80 | 17687452 15504454 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 45.80 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | CI1033 | 45.80 | 15956251 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 45.80 | 6189445 17066447 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 45.80 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 45.80 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 45.80 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 45.80 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 45.80 | 17066447 16757204 18986760 16280240 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 45.80 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 45.80 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 45.80 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 45.80 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 45.80 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 45.80 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 45.80 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 5.99 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 5.99 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Atenolol | 16.33 | 15969258 | |
| MESH:D006332 | Cardiomegaly | atorvastatin | 16.33 | 18360054 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 16.33 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 16.33 | 16170337 17124262 17287366 15728586 11754973 11179087 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 16.33 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 16.33 | 18670907 16120746 18850075 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.66 | 16612575 16364871 17007740 16731534 17974986 15792986 17382496 18627295 15811867 17519947 16952015 17131338 16278810 16109756 17924179 15505089 16242529 17329180 16455267 17928571 17308081 17351982 15476868 16651473 16269455 | |
| MESH:D002311 | Cardiomyopathy, Dilated | marker/mechanism | 18599591 | ||
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.38 | 17334414 16243910 | |
| MESH:D002318 | Cardiovascular Diseases | Aldosterone | 24.07 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 24.07 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 24.07 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 24.07 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 24.07 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | olive oil | 24.07 | 16216721 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 24.07 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 24.07 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.27 | 18022660 16973168 | |
| MESH:D002386 | Cataract | Acetaminophen | 4.43 | 10977129 | |
| MESH:D002386 | Cataract | Tretinoin | 4.43 | 17460283 | |
| MESH:D002418 | Cattle Diseases | Acrylamide | 4.27 | 12510666 | |
| MESH:D002430 | Cecal Neoplasms | 2-nitrotoluene | 4.59 | 14688030 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 28.83 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 28.83 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 28.83 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 28.83 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 28.83 | 17174075 21159647 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 28.83 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 28.83 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Ethylnitrosourea | 28.83 | 16003739 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 28.83 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 28.83 | 20056578 19524636 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 3.10 | 4080065 | |
| MESH:D016543 | Central Nervous System Neoplasms | Ethylnitrosourea | 4.79 | 17160924 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 9.09 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 9.09 | 16129372 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 3.09 | 20678186 | |
| MESH:D018281 | Cholangiocarcinoma | therapeutic | 17341899 | ||
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 5.87 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 5.87 | 16835633 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.98 | 11181007 | |
| MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 11.39 | 19486331 9022650 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 11.39 | 19486331 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 11.39 | 17110522 11677210 15861022 17681005 17333356 16105132 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 11.39 | 19176532 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.96 | 16461808 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.82 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 8.43 | 15513904 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 8.43 | 16354765 15340226 15668235 8697196 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 8.43 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 8.43 | 12810352 | |
| MESH:D003092 | Colitis | Curcumin | 13.58 | 18200517 16804969 16782535 | |
| MESH:D003092 | Colitis | resveratrol | 13.58 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 13.58 | 17936198 | |
| MESH:D003092 | Colitis | Tretinoin | 13.58 | 17035595 | |
| MESH:D003103 | Coloboma | Curcumin | 3.46 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 35.22 | 15993848 | |
| MESH:D003110 | Colonic Neoplasms | 2'-benzoyloxycinnamaldehyde | 35.22 | 14660655 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 35.22 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 35.22 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 35.22 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 35.22 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Deoxycholic Acid | 35.22 | 16213893 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 35.22 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 35.22 | 16340194 16510598 17169374 17287894 15001691 17725105 18772588 17018589 17016597 17172411 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 35.22 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 35.22 | 15786552 15625704 15936596 11260862 15637740 15963497 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 35.22 | 17725105 17287894 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 35.22 | 16004971 16510598 16024531 | |
| MESH:D003110 | Colonic Neoplasms | Piroxicam | 35.22 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 35.22 | 19440933 15741050 16640504 11134977 17148506 19056647 17191121 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 35.22 | 16338953 | |
| MESH:D015179 | Colorectal Neoplasms | marker/mechanism | 17575224 | ||
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 26.71 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 26.71 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 26.71 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 26.71 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 26.71 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 26.71 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | erlotinib | 26.71 | 17255274 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 26.71 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 26.71 | 17594712 17094418 16303861 16391804 18509181 18448328 18383874 18949393 17454858 16524972 15289873 20501625 17401013 18288408 17016601 17255274 17695437 14970324 15148649 18802399 16282729 16331619 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 26.71 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 26.71 | 17054584 12606626 18059344 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 26.71 | 16303861 17159606 18509181 16391804 17454858 18259882 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 26.71 | 17695437 18448328 18509181 17594712 17401013 17255274 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 26.71 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 26.71 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 26.71 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 26.71 | 10666051 10416599 11197048 18059344 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.03 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.74 | 18497527 | |
| MESH:D003324 | Coronary Artery Disease | atorvastatin | 3.56 | 16368305 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.88 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.06 | 12609071 | |
| MESH:D003328 | Coronary Thrombosis | methyleugenol | 7.45 | 16048847 | |
| MESH:D003328 | Coronary Thrombosis | Oxazepam | 7.45 | 16048847 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.52 | 17302372 | |
| MESH:D019465 | Craniofacial Abnormalities | marker/mechanism | 10319864 | ||
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 14.93 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 14.93 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 14.93 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 14.93 | 15451040 19302082 15513904 15451039 10194807 11198716 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 14.93 | 18769834 9879862 | |
| MESH:D019465 | Craniofacial Abnormalities | Lead | 14.93 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | lead acetate | 14.93 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 14.93 | 10048152 15322242 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 14.93 | 14991402 9224671 8800419 9142499 9664655 16925845 17551590 9211117 10589399 9125849 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 14.93 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 14.93 | 19302082 | |
| MESH:D016638 | Critical Illness | Estrogens | 4.77 | 16670151 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.43 | 16002989 12952375 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 5.74 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 5.74 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 13.10 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 13.10 | 18093676 12913760 16413132 10700343 10498854 18710439 12388444 18433785 15276878 17979934 16614059 11948286 15643279 18295254 18372110 12161096 16651033 17010015 16989017 18483878 | |
| MESH:D003556 | Cystitis | Hydrochloric Acid | 13.10 | 19279288 20719367 12853844 12599022 | |
| MESH:D018856 | Cystitis, Interstitial | Hydrochloric Acid | 4.62 | 17714534 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.62 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.99 | 15213294 | |
| MESH:D003704 | Dementia | Lead | 7.11 | 16140633 | |
| MESH:D003704 | Dementia | Methylmercury Compounds | 7.11 | 16140633 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.21 | 19031437 | |
| MESH:D003872 | Dermatitis | Benzene | 3.62 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 7.60 | 18759878 11298694 12868966 8970840 8156756 11906362 2524372 14531868 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 7.60 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 7.60 | 11298694 16780908 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 7.60 | 12956900 15491423 18759878 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.72 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 5.96 | 3621924 2952479 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 5.96 | 17010967 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 5.09 | 18854434 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 3.18 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 8.22 | 11751995 15331540 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 8.22 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 8.22 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 2.71 | 18772604 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 10.59 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 10.59 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 10.59 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 10.59 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 10.59 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 10.59 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 13.00 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 13.00 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 13.00 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 13.00 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.34 | 17187935 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 7.19 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 7.19 | 10446763 7237001 11488427 | |
| MESH:D003967 | Diarrhea | Indomethacin | 7.19 | 7907874 7237001 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 17.06 | 18289764 1440618 6482804 8291058 18692083 7440962 11289319 9328219 18648102 6679447 9653073 9022650 16192314 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 17.06 | 19420014 11461765 12392966 19739265 10774834 19416960 15968718 16081117 16109766 14986274 16177239 14725611 19085960 17906064 15619225 10663392 19370779 18071297 16485898 11421492 12153990 11529661 12540782 11834606 2444490 12958197 14550746 17522070 19923254 10915739 11739529 16227642 11743745 11287661 19164858 16781746 18713872 12705907 16393943 12594235 17562736 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 17.06 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 17.06 | 11566570 16177239 3786805 16227642 6884620 21278145 6623471 9327722 15998439 3732212 7179309 17522070 10092053 4309450 7120509 19085960 19336974 15968718 2869522 7440962 15027814 10915739 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 17.06 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 17.06 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 17.06 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Nevirapine | 17.06 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 17.06 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 17.06 | 20420201 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.91 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 8.23 | 12649298 12231392 15033597 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 8.23 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 8.23 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.97 | 18043480 17190690 18446180 16326151 16133044 12774134 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 5.73 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 5.73 | 11595431 16699067 17045617 17351913 17202747 17151854 11535926 10671773 17329845 11991626 11595415 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 5.80 | 18367378 | |
| MESH:D050171 | Dyslipidemias | Fenofibrate | 5.80 | 16707586 | |
| MESH:D004421 | Dystonia | Phenobarbital | 2.90 | 1851702 | |
| MESH:C538011 | Eales disease | Vitamin E | 3.51 | 9068938 | |
| MESH:D004476 | Ectodermal Dysplasia | Ethylnitrosourea | 4.79 | 18357618 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.34 | 12438553 | |
| MESH:D004487 | Edema | Arachidonic Acid | 26.90 | 7990266 16716910 9599246 9831321 15177302 11698051 | |
| MESH:D004487 | Edema | bisindolylmaleimide I | 26.90 | 8273558 | |
| MESH:D004487 | Edema | Dexamethasone | 26.90 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 26.90 | 8985016 7990266 10653021 7907874 16100529 8273558 19703484 | |
| MESH:D004487 | Edema | perfluorooctanoic acid | 26.90 | 17259670 12083418 | |
| MESH:D004487 | Edema | pirinixic acid | 26.90 | 12083418 | |
| MESH:D004487 | Edema | Piroxicam | 26.90 | 7907874 | |
| MESH:D004487 | Edema | resveratrol | 26.90 | 8985016 | |
| MESH:D004487 | Edema | Staurosporine | 26.90 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 26.90 | 12711302 11000095 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 8.00 | 18230668 15322242 16714409 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 8.00 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 12.84 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 12.84 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 12.84 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 12.84 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 3.92 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 8.01 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 8.01 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 29.85 | 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 29.85 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 29.85 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 29.85 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 29.85 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 29.85 | 16569247 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 29.85 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 29.85 | 20544844 19155303 16202921 17893378 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 29.85 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 13.29 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 13.29 | 15652904 | |
| MESH:D004715 | Endometriosis | Progesterone | 13.29 | 16134523 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 13.29 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 3.96 | 18037988 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 3.34 | 18509659 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.56 | 16328016 17763956 10567023 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.55 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.55 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 12.00 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 12.00 | 11298111 | |
| MESH:D004802 | Eosinophilia | Ovalbumin | 12.00 | 12689652 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 12.00 | 8156442 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 2.96 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 2.70 | 11558140 3922381 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 2.16 | 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.52 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 3.10 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 2.86 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 3.90 | 14972507 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.92 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Hydrochloric Acid | 4.62 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 24.88 | 3581430 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 24.88 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 24.88 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 24.88 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 24.88 | 16481741 15173087 17638652 15464296 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 24.88 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 24.88 | 16785472 15173087 16481741 16337965 17638652 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 24.88 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 24.88 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Piroxicam | 24.88 | 15878914 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 24.88 | 16543248 | |
| MESH:D004941 | Esophagitis | Hydrochloric Acid | 4.82 | 12928072 | |
| MESH:D004942 | Esophagitis, Peptic | Hydrochloric Acid | 4.82 | 20516732 14621274 11346197 | |
| MESH:D020329 | Essential Tremor | Lead | 4.76 | 14594619 18007985 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 5.62 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 5.62 | 16938888 9664655 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.57 | 18447907 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 37.57 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 37.57 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 37.57 | 15959796 19224547 12795759 16239168 12631006 61145 17595544 16045604 | |
| MESH:D005234 | Fatty Liver | Curcumin | 37.57 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 37.57 | 19224547 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 37.57 | 18296743 19004024 19551842 17967931 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 37.57 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 37.57 | 19236843 18620774 16409862 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 37.57 | 15345470 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 37.57 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 37.57 | 19224547 14986274 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.47 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 5.34 | 16611131 15751030 16513791 16002989 16534752 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 5.34 | 16709447 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.12 | 16946407 15513904 10194807 15451040 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.31 | 11858732 | |
| MESH:D005317 | Fetal Growth Retardation | Lead | 7.98 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | lead acetate | 7.98 | 19769572 | |
| MESH:D005334 | Fever | Arachidonic Acid | 13.25 | 11852909 | |
| MESH:D005334 | Fever | Dinoprostone | 13.25 | 11852909 16997862 | |
| MESH:D005334 | Fever | Dipyrone | 13.25 | 11852909 | |
| MESH:D005334 | Fever | Indomethacin | 13.25 | 17627676 10431976 11852909 | |
| MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 3.82 | 6705139 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.35 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 7.56 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 7.56 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 3.72 | 10962813 | |
| MESH:D005355 | Fibrosis | arsenite | 38.55 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 38.55 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 38.55 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 38.55 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 38.55 | 18296743 | |
| MESH:D005355 | Fibrosis | Hydrochloric Acid | 38.55 | 18497604 | |
| MESH:D005355 | Fibrosis | Indomethacin | 38.55 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 38.55 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 38.55 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 38.55 | 17994277 | |
| MESH:D005391 | Firesetting Behavior | Testosterone | 4.66 | 7506515 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.98 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.36 | 6392382 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.13 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Hydrochloric Acid | 4.28 | 12378975 | |
| MESH:D005756 | Gastritis | Acetaminophen | 17.70 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 17.70 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 17.70 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 17.70 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Hydrochloric Acid | 4.20 | 20516732 19957777 12212954 20616304 20545468 19951613 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.54 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.93 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.93 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.04 | 8708960 | |
| MESH:D005909 | Glioblastoma | CI1033 | 31.85 | 15956251 | |
| MESH:D005909 | Glioblastoma | Curcumin | 31.85 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 31.85 | 17150277 | |
| MESH:D005909 | Glioblastoma | Ethylnitrosourea | 31.85 | 16436596 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 31.85 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 31.85 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 31.85 | 12870263 | |
| MESH:D005909 | Glioblastoma | Quercetin | 31.85 | 19804834 | |
| MESH:D005909 | Glioblastoma | Testosterone | 31.85 | 17162496 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 31.85 | 17312396 | |
| MESH:D005910 | Glioma | Ethylnitrosourea | 8.64 | 18412241 16651633 16357521 | |
| MESH:D005910 | Glioma | Fluorouracil | 8.64 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 8.64 | 16487511 18371953 | |
| MESH:D005910 | Glioma | Quercetin | 8.64 | 17643826 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.34 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.97 | 11124998 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.28 | 11849393 | |
| MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 2.93 | 7505956 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.40 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.17 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 3.88 | 16376943 15172196 11014644 | |
| MESH:D006130 | Growth Disorders | Zinc | 3.08 | 17217573 | |
| MESH:D006258 | Head and Neck Neoplasms | marker/mechanism | 15342401 | ||
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 22.53 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 22.53 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 22.53 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 22.53 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 22.53 | 15162350 15102660 18337622 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 22.53 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 22.53 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 3.26 | 19898482 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.96 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.39 | 15464296 | |
| MESH:D006356 | Heartburn | Hydrochloric Acid | 4.62 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 9.47 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 9.47 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 9.47 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 9.47 | 16080930 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 5.05 | 16144979 12587719 16244371 17888722 17875725 18674790 14766674 16707910 16244372 16330681 18006777 16495754 16879835 | |
| MESH:D006331 | Heart Diseases | Urethane | 5.05 | 16046796 | |
| MESH:D006333 | Heart Failure | Atenolol | 20.27 | 20082655 | |
| MESH:D006333 | Heart Failure | atorvastatin | 20.27 | 16360360 | |
| MESH:D006333 | Heart Failure | Dobutamine | 20.27 | 17440445 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 20.27 | 17481944 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 20.27 | 20558911 | |
| MESH:D006333 | Heart Failure | Selenium | 20.27 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 20.27 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.57 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.43 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 4.13 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 9.27 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-nitrotoluene | 9.27 | 13678655 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 9.27 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 3.55 | 16183116 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.24 | 15720958 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 4.13 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.26 | 11000095 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.49 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.34 | 14986274 | |
| MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 5.52 | 6705139 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 5.52 | 19110552 19900420 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.55 | 15135802 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 7.51 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 7.51 | 17063115 | |
| MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 11.47 | 3609246 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 11.47 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 11.47 | 18467677 19772884 19176532 16221962 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 11.47 | 16120746 15340226 12621046 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.88 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 3.93 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 3.93 | 16863852 16490937 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.84 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 6.26 | 10809021 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 6.26 | 16876885 | |
| MESH:D006628 | Hirsutism | Testosterone | 4.46 | 17019078 | |
| MESH:D015658 | HIV Infections | Nevirapine | 4.15 | 11141242 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 15.53 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 15.53 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 15.53 | 17606976 15147373 18501091 | |
| MESH:D006689 | Hodgkin Disease | Epirubicin | 15.53 | 18180244 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 15.53 | 16135485 16200630 15147373 18180244 17606976 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 15.53 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 6.14 | 17088409 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 6.14 | 14716179 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.85 | 16959395 15340226 16354765 18606429 8697196 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 25.86 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 25.86 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 25.86 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Freund's Adjuvant | 25.86 | 16769263 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 25.86 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 25.86 | 17418472 | |
| MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 25.86 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 25.86 | 16870215 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.52 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Testosterone | 4.12 | 17019078 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.36 | 16899240 | |
| MESH:D006937 | Hypercholesterolemia | atorvastatin | 13.13 | 11583720 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 13.13 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 13.13 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 13.13 | 17188708 | |
| MESH:D006940 | Hyperemia | Hydrochloric Acid | 8.85 | 12646421 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.85 | 12524144 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.41 | 16778211 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 5.73 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 5.73 | 11834736 18262572 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.39 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 9.20 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 9.20 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 9.20 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | atorvastatin | 4.18 | 16238680 | |
| MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 7.03 | 15034207 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 7.03 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Terfenadine | 6.20 | 2570798 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 6.20 | 10880147 11019492 | |
| MESH:D006973 | Hypertension | Arsenic | 24.39 | 9931084 11953799 16076760 | |
| MESH:D006973 | Hypertension | Atenolol | 24.39 | 15614026 14597852 12717102 12022239 11593098 15188945 14700505 15453913 19249413 15237695 11910301 15969258 | |
| MESH:D006973 | Hypertension | atorvastatin | 24.39 | 17042910 | |
| MESH:D006973 | Hypertension | Benzene | 24.39 | 17940673 | |
| MESH:D006973 | Hypertension | Cyclosporine | 24.39 | 10903974 | |
| MESH:D006973 | Hypertension | daidzein | 24.39 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 24.39 | 17042910 | |
| MESH:D006973 | Hypertension | Phenylephrine | 24.39 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Quercetin | 24.39 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 24.39 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 7.60 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | Hydrochloric Acid | 7.60 | 16984587 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 5.80 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Hydrochloric Acid | 5.80 | 19262391 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 3.47 | 12791704 18502941 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | Atenolol | 7.36 | 15237695 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 7.36 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 5.06 | 18424623 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.36 | 16093927 | |
| MESH:D007006 | Hypogonadism | Testosterone | 3.65 | 12002444 | |
| MESH:D007018 | Hypopituitarism | Testosterone | 5.00 | 17426086 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 7.43 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 7.43 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Hydrochloric Acid | 6.12 | 11574821 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 6.12 | 7265320 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.84 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.17 | 16133968 10647630 10651667 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 4.14 | 16076520 | |
| MESH:D007174 | Impulse Control Disorders | Testosterone | 4.66 | 7506515 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 4.18 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 7.67 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 7.67 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 3.23 | 15036965 | |
| MESH:D007247 | Infertility, Female | Acrylamide | 6.73 | 11020651 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 6.73 | 12013081 | |
| MESH:D007248 | Infertility, Male | Acrylamide | 21.71 | 15355880 11020651 12507653 15749267 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 21.71 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | decitabine | 21.71 | 17581917 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 21.71 | 17937319 | |
| MESH:D007248 | Infertility, Male | Lead | 21.71 | 16780224 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 21.71 | 16467254 11955947 | |
| MESH:D007248 | Infertility, Male | Paraquat | 21.71 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 21.71 | 12646999 15346721 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 36.39 | 15177302 17371808 9831321 | |
| MESH:D007249 | Inflammation | atorvastatin | 36.39 | 16908763 | |
| MESH:D007249 | Inflammation | bisindolylmaleimide I | 36.39 | 8273558 | |
| MESH:D007249 | Inflammation | Curcumin | 36.39 | 18403477 17151092 16956363 | |
| MESH:D007249 | Inflammation | Dexamethasone | 36.39 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Dietary Fats | 36.39 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 36.39 | 18785209 | |
| MESH:D007249 | Inflammation | Freund's Adjuvant | 36.39 | 16793879 | |
| MESH:D007249 | Inflammation | Hydrochloric Acid | 36.39 | 11574821 | |
| MESH:D007249 | Inflammation | Indomethacin | 36.39 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | perfluorooctanoic acid | 36.39 | 12083418 | |
| MESH:D007249 | Inflammation | Progesterone | 36.39 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 36.39 | 16366677 | |
| MESH:D007249 | Inflammation | Tamoxifen | 36.39 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 36.39 | 12878042 12200463 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.58 | 18200517 18596194 | |
| MESH:D007251 | Influenza, Human | Quercetin | 17.02 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 17.02 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 17.02 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 17.02 | 16624496 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 10.33 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 10.33 | 11836018 18457598 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 10.33 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 10.33 | 16306350 | |
| MESH:D007410 | Intestinal Diseases | Hydrochloric Acid | 10.02 | 11574821 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 10.02 | 10210152 11686837 11713966 17994277 15831440 18236018 15610444 11855677 17329856 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 10.02 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 6.96 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Piroxicam | 6.96 | 10213222 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.18 | 15241188 | |
| MESH:D007511 | Ischemia | Zinc | 3.49 | 16584753 | |
| MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 3.82 | 8074119 9022650 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 10.95 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.95 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.95 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.84 | 18306037 16133968 10574470 | |
| MESH:D007627 | Keloid | Quercetin | 3.80 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.25 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.82 | 12749816 16930632 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.46 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.95 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 29.95 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 29.95 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 29.95 | 15190930 12649298 12231392 18289764 19839026 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 29.95 | 18776723 10903974 8314463 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 29.95 | 16775033 15699352 15369732 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 29.95 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 29.95 | 17190690 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 29.95 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 29.95 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 29.95 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 29.95 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 15.06 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 15.06 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 15.06 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 15.06 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 23.67 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 23.67 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 23.67 | 15003126 14681315 16762066 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 23.67 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Ethylnitrosourea | 23.67 | 17379185 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 23.67 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 23.67 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 23.67 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.61 | 11231351 | |
| MESH:D007818 | Laryngeal Diseases | Hydrochloric Acid | 5.17 | 16498863 | |
| MESH:D007826 | Laryngismus | Hydrochloric Acid | 5.17 | 11510729 | |
| MESH:D007855 | Lead Poisoning | Lead | 4.76 | 16700817 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 9.73 | 17184923 | |
| MESH:D007859 | Learning Disorders | Ethanol | 9.73 | 15451040 | |
| MESH:D007859 | Learning Disorders | Lead | 9.73 | 16384672 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.47 | 18555241 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 5.46 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 5.46 | 15237267 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 25.25 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 25.25 | 15070760 | |
| MESH:D007938 | Leukemia | Benzene | 25.25 | 14694614 17119257 18335105 15935818 | |
| MESH:D007938 | Leukemia | Curcumin | 25.25 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 25.25 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 25.25 | 19235587 18980019 | |
| MESH:D007938 | Leukemia | Genistein | 25.25 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | Quercetin | 25.25 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 25.25 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.96 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 2.84 | 18172266 17008537 17296974 17802794 18587576 17658394 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 6.18 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 6.18 | 16106398 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 18.61 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 18.61 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 18.61 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 18.61 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 8.60 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 8.60 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 8.60 | 10785260 15631656 16572323 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 14.06 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 14.06 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 14.06 | 17236224 18454857 19117987 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 14.06 | 19285840 16932348 16482212 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 9.30 | 16467208 17077328 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 9.30 | 16968895 16467208 17050201 20471514 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 9.30 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 9.30 | 18206229 18460780 19387464 17679729 18704418 19010910 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 9.30 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 9.30 | 19850784 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.27 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 14.47 | 17077328 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 14.47 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 14.47 | 16112521 15336539 19642359 17869043 11161223 15622746 17107899 12018890 17712046 16966277 16891316 19225113 15213294 15748426 16823087 17217047 19075265 12679006 12712474 16331271 17649720 16330433 11468182 9834237 19035177 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 14.47 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 14.47 | 17649720 19225113 16823087 17506722 17294898 17217047 17107899 16766008 17361223 15748426 17712046 12679006 9834237 17368321 17339181 16331271 16788101 17301526 16891316 19029980 19075265 16935935 19035177 16140955 19642359 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.97 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.97 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.18 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.52 | 17980183 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 3.80 | 10052129 11830472 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.85 | 16707609 | |
| MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 4.05 | 8812269 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 5.19 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 5.19 | 9224671 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.24 | 15342952 17567588 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.71 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.52 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 18.95 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 18.95 | 17174718 11408273 17334410 16239168 11903743 16943688 16221502 17157831 21278145 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 18.95 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 18.95 | 19638242 18407596 18522880 18665156 20032147 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 18.95 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Hydrochloric Acid | 18.95 | 16984587 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 18.95 | 21047994 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.92 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 2.33 | 9327722 15034207 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | atorvastatin | 28.30 | 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 28.30 | 16638106 17721639 17805973 18156304 18412020 12667390 15338365 18279442 17714472 18429990 18395914 12741479 16015684 17640975 18376398 18418968 16248980 18317297 15931870 15362042 18210741 17944888 12666154 10355542 17823541 16192424 18277467 18705752 15673190 15818738 14748882 15052691 15730626 16116963 18472332 18263696 12546737 12609069 14716496 12586293 17922224 12632512 18251166 14716833 12898905 12445421 12632514 12958196 17557913 16033810 11481614 18420326 15893842 15996030 15925388 17766677 18054572 17525996 18166357 17761835 17869086 18187930 18481824 16011737 20821823 18205269 17481882 18339082 14512876 17976157 18472094 15123356 14620537 16027843 17698563 13678700 12389079 15959796 12649538 17708605 18006644 17631135 14724832 17900296 16136751 15876570 15370692 18395095 12445418 17565644 15650968 16097048 15057751 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 28.30 | 18006644 17355460 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 28.30 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 28.30 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 28.30 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 28.30 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 28.30 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 28.30 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 28.30 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 28.30 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 28.30 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 28.30 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 28.30 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 28.30 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 28.30 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 28.30 | 16248980 18397230 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 28.30 | 16169303 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 13.77 | 19014921 16611625 19460945 11587558 12969438 12587719 19784758 16610002 | |
| MESH:D008107 | Liver Diseases | Arsenic | 13.77 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 13.77 | 17285989 16246199 16964402 15830285 15720792 | |
| MESH:D008107 | Liver Diseases | Curcumin | 13.77 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 13.77 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 13.77 | 15816358 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 13.77 | 19363144 | |
| MESH:D008107 | Liver Diseases | Piroxicam | 13.77 | 16867024 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.51 | 17347304 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.01 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 5.89 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 5.89 | 16899240 14706259 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 52.65 | 10672840 11376686 16273603 10737359 18001218 14678523 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 52.65 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 52.65 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 52.65 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 52.65 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 52.65 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 52.65 | 19426721 19850985 21278145 20434301 18754104 20492335 19638242 10737359 19294768 19255062 19499222 19551842 18644402 19642983 19690152 15175105 18977376 16942905 20452335 18978307 12771043 21071580 9163691 20501860 20137499 20118626 21047994 19427195 19812893 20101389 19833225 21167192 12112319 20405173 19256749 2862719 20583210 2422723 19073162 19254457 18648771 19090486 19996281 15885732 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 52.65 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Fenofibrate | 52.65 | 18978307 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 52.65 | 15113037 16603448 18383874 17045692 | |
| MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 52.65 | 14757943 18709148 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 52.65 | 19812893 8742319 19073162 19482888 15975961 21047994 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 52.65 | 15890375 19690152 20101389 18648771 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 52.65 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 52.65 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 52.65 | 19812893 20405173 19073162 19321006 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 52.65 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 52.65 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 52.65 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 52.65 | 16391232 17559639 17093202 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 39.00 | 534488 6150874 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 39.00 | 598648 1399818 6587162 3712494 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 39.00 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 39.00 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 39.00 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Deoxycholic Acid | 39.00 | 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 39.00 | 18079962 17174075 18544905 16842330 18775883 17942915 18093689 19004024 3124819 18308698 19539802 19126423 19009564 18164116 16267830 17854601 19519916 21159647 18253720 18282651 2563599 9362446 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dipyrone | 39.00 | 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 39.00 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 39.00 | 18775883 18253720 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 39.00 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 39.00 | 1399818 6150874 18308698 2563599 17172636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 39.00 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 39.00 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 8.33 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Dobutamine | 8.33 | 19353679 | |
| MESH:D008133 | Long QT Syndrome | Terfenadine | 8.33 | 8772706 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 24.92 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 24.92 | 11504702 | |
| MESH:D008171 | Lung Diseases | Asbestos, Serpentine | 24.92 | 17200189 | |
| MESH:D008171 | Lung Diseases | Dobutamine | 24.92 | 16638327 | |
| MESH:D008171 | Lung Diseases | Hydrochloric Acid | 24.92 | 16784557 | |
| MESH:D008171 | Lung Diseases | Ozone | 24.92 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 24.92 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 24.92 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 3.62 | 14698565 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 8.81 | 17365036 | |
| MESH:D055370 | Lung Injury | Hydrochloric Acid | 8.81 | 18573544 15044056 21311175 18339021 18497604 16129981 15607125 19644408 21114838 20597076 19262391 15090967 17627322 11395602 | |
| MESH:D055370 | Lung Injury | Ozone | 8.81 | 20417186 | |
| MESH:D008175 | Lung Neoplasms | marker/mechanism | |||
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 51.73 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 51.73 | 18508827 17139156 19931552 16401635 15893417 15172992 18813816 12438228 16061637 9255578 14755239 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 51.73 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 51.73 | 17976673 17306315 19168569 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 51.73 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 51.73 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Asbestos, Serpentine | 51.73 | 11198217 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 51.73 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 51.73 | 20464547 18569708 6695378 18816296 17053015 20869020 20064080 18520028 20135361 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 51.73 | 6189445 11798837 17225452 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 51.73 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 51.73 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 51.73 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 51.73 | 6695378 20970405 20512841 21163286 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 51.73 | 6189445 17418594 | |
| MESH:D008175 | Lung Neoplasms | Ethylnitrosourea | 51.73 | 16019985 17703301 16271038 6695378 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 51.73 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 51.73 | 11053908 11497255 16537180 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 51.73 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 51.73 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Piroxicam | 51.73 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 51.73 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 51.73 | 15276417 19931552 17306315 17077188 16712894 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 51.73 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 51.73 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 51.73 | 10997738 14587096 15902970 6695378 12957351 16289808 11544531 11497255 12466968 11062179 11992545 11893704 15166089 11307925 12765245 16391232 17255336 10822126 16204055 11552296 15136453 10779650 10530776 11246140 11807781 11074608 11323394 7750092 16926031 16337739 12117781 17093202 16007126 17195641 16788158 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 51.73 | 11062179 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.62 | 15086387 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.97 | 15166399 | |
| MESH:D008223 | Lymphoma | Benzene | 25.00 | 17584886 17119257 | |
| MESH:D008223 | Lymphoma | Curcumin | 25.00 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 25.00 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 25.00 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 25.00 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 25.00 | 16098063 | |
| MESH:D008223 | Lymphoma | Ethylnitrosourea | 25.00 | 15790496 | |
| MESH:D008223 | Lymphoma | Etoposide | 25.00 | 12556972 12854902 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 6.82 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 6.82 | 17088997 | |
| MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 5.44 | 17157164 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 12.45 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 12.45 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 12.45 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 12.45 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 12.87 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 12.87 | 15621674 | |
| MESH:D016399 | Lymphoma, T-Cell | Ethylnitrosourea | 12.87 | 15375218 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.32 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 10.13 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 10.13 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 10.13 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 42.88 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 42.88 | 19196722 12104042 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 42.88 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 42.88 | 11807958 11408345 16891317 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | estradiol 3-benzoate | 42.88 | 15375486 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ethylnitrosourea | 42.88 | 10767621 18041768 10838139 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 42.88 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 42.88 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 42.88 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | methyleugenol | 42.88 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 42.88 | 11408345 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 42.88 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 42.88 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 42.88 | 16827153 19196722 19196723 11731420 14580682 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 42.88 | 12773700 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.70 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.70 | 19453300 | |
| MESH:D008382 | Marfan Syndrome | Atenolol | 5.09 | 19430350 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 2.15 | 17453147 | |
| MESH:D008545 | Melanoma | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 31.28 | 16077934 | |
| MESH:D008545 | Melanoma | betulinic acid | 31.28 | 16077934 | |
| MESH:D008545 | Melanoma | Cisplatin | 31.28 | 16432458 12374674 16248763 17023156 18505091 18332650 15577323 11135225 16809738 12883367 17761969 12393984 18176117 | |
| MESH:D008545 | Melanoma | Curcumin | 31.28 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | decitabine | 31.28 | 17785578 16505122 | |
| MESH:D008545 | Melanoma | Doxorubicin | 31.28 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 31.28 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | Epirubicin | 31.28 | 16642371 | |
| MESH:D008545 | Melanoma | Fenretinide | 31.28 | 16270382 | |
| MESH:D008545 | Melanoma | Isotretinoin | 31.28 | 17237267 | |
| MESH:D008545 | Melanoma | Paclitaxel | 31.28 | 16342250 12040289 12025231 | |
| MESH:D008545 | Melanoma | resveratrol | 31.28 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 31.28 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Tamoxifen | 31.28 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 31.28 | 16752155 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 31.28 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 7.63 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 7.63 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 11.88 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 11.88 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 11.88 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 13.70 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 13.70 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | Lead | 13.70 | 16384672 17263510 | |
| MESH:D008569 | Memory Disorders | Methylmercury Compounds | 13.70 | 18436314 | |
| MESH:D008579 | Meningioma | Ethylnitrosourea | 4.79 | 17943659 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.27 | 16940565 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 9.00 | 18303189 16966607 16166281 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 9.00 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 9.00 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 9.00 | 15107826 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.29 | 17112576 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.59 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.91 | 10496685 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 2.78 | 11903285 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 4.14 | 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.41 | 15792986 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 12.56 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 12.56 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 12.56 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 12.56 | 12636206 | |
| MESH:D009069 | Movement Disorders | Methylmercury Compounds | 4.22 | 18436314 | |
| MESH:D052016 | Mucositis | Doxorubicin | 8.53 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 8.53 | 17159606 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 23.70 | 14977855 19549372 19417148 15949261 11468182 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 23.70 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 23.70 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 23.70 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 23.70 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 23.70 | 15867202 16118317 15744524 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 23.70 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 23.70 | 14749477 16490592 17164350 17049120 17935668 16267019 | |
| MESH:D019042 | Muscle Neoplasms | 2-nitrotoluene | 5.49 | 13678655 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 14.42 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 14.42 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 14.42 | 17962980 | |
| MESH:D009135 | Muscular Diseases | atorvastatin | 6.95 | 16239165 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 6.95 | 16239165 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.48 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 10.78 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 10.78 | 19010910 18608210 16882708 19157545 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 10.78 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 10.78 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 13.50 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 13.50 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Hydrochloric Acid | 13.50 | 18534312 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 13.50 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 13.50 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 13.50 | 16456233 17188708 16317513 16525036 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 13.74 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Dobutamine | 13.74 | 12447174 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 13.74 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 13.74 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 12.31 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 12.31 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 12.31 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 12.31 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.59 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 3.30 | 17484760 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 6.60 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 6.60 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | marker/mechanism | 17575224 17369752 | ||
| MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 20.19 | 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 20.19 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 20.19 | 3581430 9029167 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 20.19 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 20.19 | 11239499 16537180 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 20.19 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 20.19 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 20.19 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.97 | 19410462 | |
| MESH:D009369 | Neoplasms | 2'-benzoyloxycinnamaldehyde | 43.56 | 17855188 | |
| MESH:D009369 | Neoplasms | Acrolein | 43.56 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 43.56 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 43.56 | 11141357 | |
| MESH:D009369 | Neoplasms | Cisplatin | 43.56 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 43.56 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 43.56 | 19116145 17925555 19470736 | |
| MESH:D009369 | Neoplasms | deguelin | 43.56 | 17764071 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 43.56 | 15313581 | |
| MESH:D009369 | Neoplasms | Fenretinide | 43.56 | 15958647 17353921 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 43.56 | 18239605 18600527 16928823 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 43.56 | 17405874 | |
| MESH:D009369 | Neoplasms | Piroxicam | 43.56 | 16684565 | |
| MESH:D009369 | Neoplasms | Quercetin | 43.56 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 43.56 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 43.56 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Urethane | 43.56 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Asbestos, Serpentine | 25.41 | 11704859 | |
| MESH:D009374 | Neoplasms, Experimental | Ethylnitrosourea | 25.41 | 16707424 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 25.41 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 25.41 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 25.41 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 25.41 | 1670384 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 25.41 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 16.60 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 16.60 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Nevirapine | 16.60 | 19152342 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 16.60 | 19200415 19189210 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 6.30 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 6.30 | 17289903 | |
| MESH:D009393 | Nephritis | Acrolein | 5.09 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.32 | 15464296 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.62 | 16636307 16899518 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.25 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | atorvastatin | 9.91 | 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 9.91 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 9.91 | 15640375 16889571 | |
| MESH:D009410 | Nerve Degeneration | Acrylamide | 8.61 | 12387366 11264303 12387367 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 8.61 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 8.61 | 17356569 18619942 15790535 | |
| MESH:D009422 | Nervous System Diseases | Acrylamide | 3.95 | 12164553 12507653 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 24.00 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 24.00 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 24.00 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 24.00 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 24.00 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 24.00 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.43 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 20.71 | 6679447 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 20.71 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 20.71 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 20.71 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 20.71 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 20.71 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 20.71 | 9142499 | |
| MESH:D009442 | Neurilemmoma | Ethylnitrosourea | 4.24 | 17160924 16003739 16651423 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 13.09 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 13.09 | 15176712 8761367 16115947 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 13.09 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 13.09 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 13.09 | 17368321 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 15.74 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 15.74 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 15.74 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 15.74 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 15.74 | 17652729 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 12.40 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 12.40 | 8761367 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 12.40 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 11.46 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 11.46 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 11.46 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.92 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.50 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 2.55 | 16436463 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 3.25 | 8291058 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 3.80 | 9802331 | |
| MESH:D009765 | Obesity | Curcumin | 4.51 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 4.51 | 17217161 18457598 19632207 16723640 21332399 20132043 18674790 11836018 20518802 | |
| MESH:D009765 | Obesity | pirinixic acid | 4.51 | 20558911 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.98 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 13.13 | 6482804 4026338 | |
| MESH:D009784 | Occupational Diseases | Benzene | 13.13 | 15935809 17119257 15727169 17178637 15612468 15576619 15913788 17479406 16737584 | |
| MESH:D009784 | Occupational Diseases | Hydrochloric Acid | 13.13 | 12378975 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 13.13 | 18394133 11077013 3040596 8156442 6091946 12585506 6091945 | |
| MESH:D009837 | Oligodendroglioma | Ethylnitrosourea | 4.79 | 17160924 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.55 | 16517039 | |
| MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 3.82 | 3988306 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 2.84 | 7009135 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 5.28 | 18500342 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 3.81 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 3.19 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 4.52 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 4.52 | 19401787 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 10.56 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 10.56 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 10.56 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 3.11 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.81 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | marker/mechanism | 16211241 | ||
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 55.06 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 55.06 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 55.06 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 55.06 | 16624393 19769630 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 55.06 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 55.06 | 15464296 19769630 6897625 17225452 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 55.06 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 55.06 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 55.06 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 55.06 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 55.06 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 55.06 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 55.06 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 55.06 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 55.06 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 55.06 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 55.06 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 55.06 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 55.06 | 16391232 | |
| MESH:D010146 | Pain | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 10.81 | 18987195 | |
| MESH:D010146 | Pain | Acetaminophen | 10.81 | 16870215 | |
| MESH:D010146 | Pain | Cyclophosphamide | 10.81 | 12161096 18093676 | |
| MESH:D010146 | Pain | Indomethacin | 10.81 | 13679232 17440234 3291741 17627676 | |
| MESH:D010146 | Pain | Tretinoin | 10.81 | 16870215 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.50 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 42.76 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 42.76 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 42.76 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 42.76 | 17440100 19196508 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 42.76 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 42.76 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 42.76 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 42.76 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 42.76 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 42.76 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 42.76 | 16500647 16929163 15113037 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 42.76 | 11504793 18992248 17440100 18383843 16929163 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 42.76 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 42.76 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 42.76 | 15976015 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 2.87 | 17883296 15028970 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.58 | 11578682 | |
| MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 5.55 | 7296757 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 5.55 | 12065085 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 3.06 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.52 | 16537180 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 7.20 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Eugenol | 7.20 | 17329831 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 7.20 | 16140633 11445065 11181820 12911755 11124998 16510128 15824117 15451049 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 7.20 | 19114014 18619942 11535288 18191903 11445065 15451049 19232380 16412576 16140633 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.29 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 5.88 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 5.88 | 18197244 15795934 15927086 15574749 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.52 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.05 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.97 | 11148446 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.73 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Acrylamide | 10.27 | 11510240 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 10.27 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 10.27 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 3.82 | 6392382 16905509 15371236 | |
| MESH:D010538 | Peritonitis | Ozone | 3.00 | 16369182 | |
| MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 9.14 | 6228378 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 9.14 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.96 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 3.98 | 14722030 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 8.32 | 16977796 15687265 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 8.32 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.69 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 8.83 | 10923243 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Serpentine | 8.83 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.99 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.99 | 17638057 | |
| MESH:D011014 | Pneumonia | Ozone | 7.20 | 18381685 18929643 18007984 | |
| MESH:D011014 | Pneumonia | Paraquat | 7.20 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Hydrochloric Acid | 4.20 | 18573544 18497604 15607125 15970105 | |
| MESH:D017044 | Polycystic Kidney, Autosomal Recessive | marker/mechanism | 9486961 | ||
| MESH:D017499 | Porokeratosis | alitretinoin | 4.81 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 7.36 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 7.36 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 13.43 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 13.43 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 13.43 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 13.43 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 5.09 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 5.09 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 3.20 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.97 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 33.36 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 33.36 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 33.36 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Lead | 33.36 | 16384672 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Methylmercury Compounds | 33.36 | 18436314 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 33.36 | 17132714 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 33.36 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 33.36 | 11222880 11896295 11118676 11399792 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 3.57 | 17616702 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 11.81 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 11.81 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 11.81 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism|therapeutic | 17914592 15302576 17136230 | ||
| MESH:D011471 | Prostatic Neoplasms | AGN 194204 | 15.04 | 16000583 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 15.04 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 15.04 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 15.04 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 15.04 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 15.04 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 15.04 | 11398177 18226269 15129424 18156803 10851300 18769126 12497104 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 15.04 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 15.04 | 15846301 17136230 15046698 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 15.04 | 15749863 16888761 16868541 16729912 15897917 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 15.04 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 15.04 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 15.04 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 15.04 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 15.04 | 17914592 16685379 15651060 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 15.04 | 15378649 16925846 15256057 | |
| MESH:D011471 | Prostatic Neoplasms | Nevirapine | 15.04 | 19152342 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 15.04 | 16356831 17172428 17136230 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 15.04 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 15.04 | 16731767 17804756 17675339 17636462 15767336 17718901 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 15.04 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 15.04 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 15.04 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 15.04 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 15.04 | 16606632 16517595 16700911 12429649 | |
| MESH:D011507 | Proteinuria | Arsenic | 9.19 | 21343184 | |
| MESH:D011507 | Proteinuria | Indomethacin | 9.19 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 9.19 | 16636307 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 2.17 | 16919318 15861022 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 3.31 | 12752131 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 1.66 | 16882103 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.74 | 18769834 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.62 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.61 | 10548101 | |
| MESH:D001261 | Pulmonary Atelectasis | Hydrochloric Acid | 4.82 | 20597076 | |
| MESH:D011654 | Pulmonary Edema | Hydrochloric Acid | 4.04 | 15090967 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.46 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 4.43 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 13.33 | 17365031 17322281 17975199 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Serpentine | 13.33 | 18569384 15511213 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 13.33 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | erlotinib | 13.33 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 13.33 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 13.33 | 16324872 17997886 | |
| MESH:D012004 | Rectal Neoplasms | marker/mechanism | 16839708 | ||
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.97 | 16160472 18722050 18286688 15538739 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 10.72 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 10.72 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 10.72 | 17922066 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.39 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Leukotriene C4 | 6.76 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 6.76 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 6.76 | 17058453 16314181 16317513 15827377 17520802 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 16.81 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 16.81 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 16.81 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Hydrochloric Acid | 16.81 | 16784557 18549715 18339021 16129981 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 16.81 | 11700416 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 3.55 | 16940033 20219652 7692837 | |
| MESH:D012133 | Respiratory Paralysis | Hydrochloric Acid | 5.17 | 11510729 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 2.93 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.70 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Hydrochloric Acid | 7.30 | 20516732 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 7.30 | 18447907 | |
| MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 13.44 | 3692021 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 13.44 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 13.44 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 13.44 | 16584753 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 7.28 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 7.28 | 16116481 16283617 | |
| MESH:D012220 | Rhinitis | Ovalbumin | 6.20 | 12689652 18298128 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 6.20 | 19050374 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Terfenadine | 8.05 | 8201490 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 8.05 | 12617775 15015336 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 4.32 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.27 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 6.06 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 6.06 | 18313854 17203757 17710206 15625365 15675481 16767912 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 20.52 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 20.52 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 20.52 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 20.52 | 14601052 16326096 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 20.52 | 14601052 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.62 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.35 | 16862918 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.72 | 16636934 | |
| MESH:D012640 | Seizures | Ethanol | 3.32 | 9754883 | |
| MESH:D012640 | Seizures | Phenobarbital | 3.32 | 16876388 3137016 4039156 11442880 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.64 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 3.06 | 18389075 | |
| MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 5.00 | 16631401 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.54 | 7327846 | |
| MESH:D012871 | Skin Diseases | Arsenic | 5.07 | 17548696 17938729 17050553 17453740 16702368 16759981 16353154 19834688 15952646 18709164 6392382 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 5.07 | 17431481 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 5.07 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 33.01 | 19538983 17050553 15504454 16251483 17976673 17029826 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 33.01 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 33.01 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 33.01 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 33.01 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 33.01 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 33.01 | 8985016 15837718 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 33.01 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 33.01 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 33.01 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 33.01 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 33.01 | 11807781 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.15 | 15464296 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 4.32 | 19075512 19050374 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.42 | 16767912 17203757 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 13.31 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 13.31 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 13.31 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.34 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 7.00 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 7.00 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.81 | 12854658 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 10.64 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 10.64 | 15038085 10192188 17638125 17160473 18545984 10486359 16280098 10215738 16113693 15472012 16184426 17207306 18209964 | |
| MESH:D013272 | Stomach Diseases | phosphoramidon | 10.64 | 16280098 | |
| MESH:D013274 | Stomach Neoplasms | therapeutic | 15723263 | ||
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 19.22 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 19.22 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 19.22 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 19.22 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 19.22 | 15958060 18396642 17522103 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 19.22 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 19.22 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 19.22 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 19.22 | 18396642 19015929 16424979 18567086 15786421 17498489 17522103 16951190 19084572 17172411 | |
| MESH:D013274 | Stomach Neoplasms | Folfox protocol | 19.22 | 18505590 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 19.22 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 19.22 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 19.22 | 18506536 18396642 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 19.22 | 17261132 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 40.61 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Aluminum Silicates | 40.61 | 16335828 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 40.61 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 40.61 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 40.61 | 9211565 16755016 9562338 17918041 17189318 11906479 | |
| MESH:D013276 | Stomach Ulcer | Eugenol | 40.61 | 18543354 | |
| MESH:D013276 | Stomach Ulcer | Hydrochloric Acid | 40.61 | 16755016 17189318 15309881 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 40.61 | 12077510 16169175 10878458 12787963 15138204 17654042 15104355 18237397 17918041 17977527 17135157 16934674 18543354 11595415 1323529 11595431 10423059 18181030 16150113 17657623 16397915 14567935 17895592 18726076 10750652 11523592 16755016 18209962 17627676 16631530 18431645 11906479 16252198 15255614 11145282 18299717 12500499 12467913 11729361 18087811 12498302 18193104 | |
| MESH:D013276 | Stomach Ulcer | malabaricone B | 40.61 | 17977527 | |
| MESH:D013276 | Stomach Ulcer | malabaricone C | 40.61 | 17977527 | |
| MESH:D013276 | Stomach Ulcer | olive oil | 40.61 | 12498302 16252198 | |
| MESH:D013276 | Stomach Ulcer | phosphoramidon | 40.61 | 11145282 | |
| MESH:D013276 | Stomach Ulcer | Piroxicam | 40.61 | 15309881 | |
| MESH:D020521 | Stroke | Acrolein | 5.68 | 16269634 | |
| MESH:D020521 | Stroke | Vitamin E | 5.68 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.41 | 16321402 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.84 | 16045194 16684133 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.20 | 9754883 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 3.89 | 12837982 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.65 | 16930453 | |
| MESH:D013733 | Testicular Diseases | Acrylamide | 4.07 | 15864552 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.52 | 15464296 17225452 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.52 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.13 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 8.32 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Ethylnitrosourea | 8.32 | 15790496 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.71 | 12697716 | |
| MESH:D018382 | Thyroid Hormone Resistance Syndrome | Atenolol | 5.23 | 9349583 | |
| MESH:D013964 | Thyroid Neoplasms | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 43.26 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 43.26 | 6582329 3712494 6587162 7505956 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 43.26 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | AEE 788 | 43.26 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 43.26 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 43.26 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 43.26 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 43.26 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 43.26 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 43.26 | 14736730 11352223 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | 43.26 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 43.26 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 43.26 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.49 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 15.02 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 15.02 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 15.02 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 15.02 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 10.91 | 15213294 | |
| MESH:D016171 | Torsades de Pointes | Dobutamine | 10.91 | 19353679 | |
| MESH:D016171 | Torsades de Pointes | Terfenadine | 10.91 | 8256756 | |
| MESH:D014202 | Tremor | Lead | 4.31 | 21145352 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 2.37 | 16040207 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.72 | 10574470 17380554 | |
| MESH:D001749 | Urinary Bladder Neoplasms | marker/mechanism | 11723127 | ||
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 43.64 | 15867355 1399818 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 43.64 | 8074119 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 43.64 | 17976673 11144890 18640142 19429237 19322015 15987713 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 43.64 | 12845720 20435036 12973940 11780464 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 43.64 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 43.64 | 17225452 12973940 15464296 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 43.64 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 43.64 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 43.64 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 43.64 | 16712894 16452187 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 43.64 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 43.64 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 43.64 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 43.64 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 43.64 | 16712894 17306315 11723127 16452187 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 43.64 | 8653321 17572228 16712894 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 4.09 | 18462866 | |
| MESH:D014581 | Urticaria | Acetaminophen | 8.83 | 10982225 | |
| MESH:D014581 | Urticaria | Piroxicam | 8.83 | 10982225 | |
| MESH:D014581 | Urticaria | Terfenadine | 8.83 | 2569995 2885854 2565098 2859714 2568013 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 33.83 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 33.83 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 33.83 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 33.83 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 33.83 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 33.83 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 33.83 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 33.83 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 9.87 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 9.87 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 18.31 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 18.31 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 18.31 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 18.31 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 18.31 | 17044934 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.88 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.88 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 7.83 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 7.83 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 7.28 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 7.28 | 16002989 16513791 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 7.97 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.97 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.40 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.72 | 10620525 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.46 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 6.55 | 17678736 16364871 17334414 17638931 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 6.55 | 17488730 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.93 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 7.60 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 7.60 | 11897121 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.05 | 15886252 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 2.70 | 16723640 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.92 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Estrogens | 3.75 | 11172683 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 3.25 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:04520 | Adherens junction |
| REACT:18266 | Axon guidance |
| KEGG:05219 | Bladder cancer |
| KEGG:04020 | Calcium signaling pathway |
| KEGG:04060 | Cytokine-cytokine receptor interaction |
| KEGG:04320 | Dorso-ventral axis formation |
| KEGG:04144 | Endocytosis |
| KEGG:05213 | Endometrial cancer |
| KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection |
| KEGG:04012 | ErbB signaling pathway |
| KEGG:04510 | Focal adhesion |
| KEGG:04540 | Gap junction |
| KEGG:05214 | Glioma |
| KEGG:04912 | GnRH signaling pathway |
| KEGG:05160 | Hepatitis C |
| KEGG:04010 | MAPK signaling pathway |
| KEGG:04013 | MAPK signaling pathway - fly |
| KEGG:05218 | Melanoma |
| KEGG:05223 | Non-small cell lung cancer |
| KEGG:05212 | Pancreatic cancer |
| KEGG:05200 | Pathways in cancer |
| KEGG:05215 | Prostate cancer |
| KEGG:04810 | Regulation of actin cytoskeleton |
| REACT:9417 | Signaling by EGFR |
| Releated gene ID | Related gene Name |
|---|---|
| PA7360 | EGFR |
| PA29519 | HSP90AA1 |
| PA43 | AGTR1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA445857 | Thyroid Neoplasms |
| PA446661 | Carcinoma, Small Cell |
| PA165108401 | Acute coronary syndrome |
| PA445742 | Stomach Neoplasms |
| PA444283 | Glioblastoma |
| PA443756 | Colonic Neoplasms |
| PA445218 | Pancreatic Neoplasms |
| PA444818 | Lung Neoplasms |
| PA443622 | Carcinoma, Non-Small-Cell Lung |
| PA445062 | Neoplasms |
| PA443610 | Carcinoma |
| PA443560 | Breast Neoplasms |
| PA443378 | Anorexia |
| PA443899 | Diarrhea |
| PA443937 | Drug Toxicity |
| PA444153 | Fatigue |
| PA445048 | Nausea |
| PA446051 | Vomiting |
| Releated drug ID | Related drug Name |
|---|---|
| PA165290933 | Pertuzumab |
| PA449383 | docetaxel |
| PA450085 | irinotecan |
| PA165110775 | SN-38 |
| PA10040 | cetuximab |
| PA448478 | l-arginine |
| PA450635 | nitric oxide |
| PA448948 | chloroquine |
| PA152031327 | geldanamycin |
| PA452642 | podophyllotoxin derivatives |
| PA150481186 | topoisomerase I inhibitors |
| PA449014 | cisplatin |
| PA449748 | gemcitabine |
| PA131301952 | gefitinib |
| PA452621 | antineoplastic agents |
| PA134687924 | erlotinib |
| PA134687925 | canertinib |
| PA134687926 | EKB-569 |
| PA134687923 | GW2016 |
| PA152241907 | lapatinib |
| PA152241908 | PHA-665752 |
| PA451743 | trastuzumab |
| PA164749238 | exenatide |
| PA165291472 | neratinib |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00002 | inhibitor | Cetuximab | Antineoplastic Agents |
| DB00072 | - | Trastuzumab | Antineoplastic Agents |
| DB00281 | antagonist | Xylonor Spray | Antiarrhythmic Agents;Anesthetics;Anesthetics, Local;Anti-Arrhythmia Agents |
| DB00317 | antagonist | Gefitinib | Antineoplastic Agents;Protein Kinase Inhibitors |
| DB00530 | inhibitor | Erlotinib | Protein Kinase Inhibitors |
| DB01259 | antagonist | Lapatinib | Antineoplastic Agents;Protein Kinase Inhibitors |
| DB01269 | suppressor | Panitumumab | Antineoplastic Agents |
| DB02584 | - | N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine | Antineoplastic Agents;Protein Kinase Inhibitors |
| DB03496 | - | Flavopiridol | Antineoplastic Agents;Growth Inhibitors;Protein Kinase Inhibitors;Glycogen Phosphorylase inhibitor |
| DB07602 | - | S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE | |
| DB07662 | - | N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE | |
| DB07998 | - | 3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY-6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN-4(1H)-YLIDENE]ANILINE |
| No data |
| No data |
| No data |